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Proteins are important molecular machines within cells. Ability to modulate and 
engineer proteins serves as important tools to understand their structure and function. 
Different methods are available to engineer proteins. These include protein evolution 
methods and enzyme-based methods to introduce artificial functionalities. Protein 
evolution can give rise to useful proteins that can fulfill biotechnological and 
industrial applications. Protein engineering methods which add on small molecule 
tags site-specifically have many applications including bio-imaging, where by 
specifically adding a fluorescent tag onto a protein, one can study protein dynamics, 
localization, cell movement and cell growth. Site-specific modification of proteins has 
also found use in the field of microarrays, where adding on tags such as biotin to a 
protein allow it to be specifically immobilized onto an avidin-coated surface. 
Different approaches to protein engineering and modulation using the phage display 
method and the intein splicing strategy were evaluated in this report. 
 
A strategy for the immobilization of proteins site-specifically via the N-terminus onto 
the microarray was developed. The chosen model proteins were cloned into a vector 
system that facilitates the expression of the protein with an N-terminal intein fusion. 
An extra cysteine residue was introduced at the junction of the intein and protein 
fusion. Upon expression of the intein-protein fusion, intein splices out leaving the 
protein with an N-terminal cysteine. The proteins thus produced can then be applied 
to thioester-functionalized slides for uniform orientation. As a complementary 
approach, a system to biotinylate the C-terminus of proteins derived from yeast was 
set up. The expression levels and the splicing patterns of three different intein fusion 
 vii
constructs were studied. Optimal conditions for biotinylation of a model protein were 
achieved and the immobilization efficiency onto to an avidin microarray was 
evaluated.  
 
As an approach to protein engineering for the enzyme Sortase, a selection scheme for 
the evolution of increased activity of Sortase on phage has been devised. Sortase is a 
transpeptidase, which catalyzes the transfer of N-terminal glycine peptides to the 
sorting motif LPETG found in proteins. Studies of Sortase revealed that it could be 
used for attaching small molecule tags to proteins and that Sortase is not a very robust 
enzyme in vitro. A selection scheme has been devised to select for mutants of Sortase 
with improved activity by displaying them on the surface of the phage. Using this 
selection method and a suitable screening system, Sortase may be evolved into a more 
active enzyme.  
 
Phage display library displaying random peptides was scanned for good binders to the 
active site mutant of SARS main protease 3CL. Using the affinity selection method in 
phage display, multiple rounds of selection were carried out.  A binding assay at the 
end selection revealed the existence of weak binders to the protease. Several 
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1. INTRODUCTION  
1.1 Protein engineering 
Proteins are the most important work horses in the cells; they serve myriad functions 
and are also important structural determinants within cells. Ability to modulate and 
engineer proteins serves as important tools to understand their structure and function 
[1], it can also give rise to useful proteins that can fulfill biotechnological and 
industrial applications [2]. The terms “Protein engineering” and “modulation” are 
used in the following context throughout the thesis and are defined as, “Processes of 
modifying the structure of proteins or introducing unnatural functionalities to create 
tailor-made proteins serving useful applications”. Several methods that exist to 
modify and engineer proteins can be broadly grouped into 2 different categories. (a) 
Rational design and Protein evolution methods to create novel functions or improve 
existing functions. (b) Enzyme-based methods to introduce unnatural but useful 
functionalities.  
 
1.1.1 Rational design and protein evolution to create novel functions or 
improve existing functions. 
Proteins as such are pretty robust inside cells, but their performance is typically 
hampered outside natural environments and several proteins fail to behave well in 
industrial applications [2, 3]. Traditionally the approach to study and design proteins 
with improved or novel function has been through the genetic method of site directed 
mutagenesis [1]. It requires detailed knowledge of protein structure and has the 
limitation in that substitution of desired amino acids can be done only with their 
natural amino counterparts.  Proteins are complex entities and more often it is very 
difficult to predict exactly what structural changes will give rise to the desired 
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function. These limitations can be overcome by taking the proteins through the 
process of protein evolution [4], which mimics the natural process of evolution in the 
laboratory test tube. The key points of the protein evolution methods are mutagenesis 
and selection of the fittest. A repertoire of random mutants of a desired gene is created 
using genetic methods like error prone PCR or gene shuffling and linked to a suitable 
genetic coding system like phage display. The pool of mutants is then passed through 
a selection/screening assay that select for the mutants with the desired function. The 
genetic pool is culled periodically of undesirable mutations through a negative 
selection if possible. The whole process of mutagenesis and selection/screen may then 
be repeated until the proteins with desirable functions evolve [5]. Thus it is in essence 
bringing natural evolution to the test tube.  
 
1.1.2 Protein engineering : introducing artificial functionalities using enzyme- 
mediated approaches  
Several enzymes that can site specifically add on small molecule functionalities have 
been exploited to modify proteins. Some of them include Inteins [6-11], Biotin ligases 
[12], Sortase [13], Sfp phosphopantetheinyl transferase [14] and Amino Acyl - tRNA-
transferases [15-19]. Protein engineering methods which add on small molecule tags 
site specifically have many applications. One such example is in the field of bio-
imaging, where by specifically adding on fluorescent tags onto proteins, one can study 
protein dynamics, localization, cell movement and cell growth [20, 21]. Site-specific 
modification of proteins has also found use in the field of microarrays, where adding 
on tags like biotin to a protein allows it to be specifically immobilized onto an avidin-
coated surface [10, 11, 22]. 
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1.1.3 The three different approaches to protein engineering and modulation 
that were evaluated in this report 
In this report, three different approaches to protein engineering and modulation were 
evaluated. As one of the approaches to protein engineering, a strategy for the 
immobilization of proteins site-specifically via the N-terminus onto the microarray 
was developed. The chosen model proteins were cloned into a vector system that 
facilitates the expression of the protein with an N-terminal intein fusion. An extra 
cysteine residue was introduced at the junction of the intein and protein fusion. Upon 
expression of the intein-protein fusion, intein splices out, leaving the protein with an 
N-terminal cysteine. The proteins thus produced can then be applied onto thioester-
functionalized slides for uniform orientation. As a complementary approach, a system 
to biotinylate the C-termini of proteins derived from yeast was set up. The expression 
levels and the splicing patterns of three different intein fusion constructs were studied. 
Optimal condition for biotinylation of a model protein was achieved and the 
immobilization efficiency onto to an avidin microarray was evaluated. Once the 
system was established it was foreseen that important enzymes present in the yeast 
namely the kinases, phosphatases and proteases could be immobilized using this 
versatile method to generate an enzyme array. The enzymes could then be studied in a 
high throughput fashion using some of the available activity-based fluorescent probes 
in our lab [23-26]. 
 
As an approach to protein engineering, a selection scheme for the evolution of 
increased activity of SrtA on phage has been devised. SrtA is a transpeptidase, which 
catalyzes the transfer of N-terminal glycine peptides to the sorting motif LPETG 
found in proteins. Studies of SrtA revealed that it could be used for attaching small 
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molecule tags to proteins and that SrtA is not very robust in vitro. A selection scheme 
has been devised to select for mutants of SrtA with improved activity by displaying 
them on the surface of the phage. Using this selection method and a suitable screening 
system, SrtA could be evolved into a more active enzyme. 
  
Phage display library displaying random peptides was scanned for good binders to the 
active site mutant of SARS main protease 3CL. Using the affinity selection method in 
phage display, multiple rounds of selection were carried out.  A binding assay at the 
end of multiple rounds of selection revealed the existence of weak binders to the 
protease. Several candidate peptides that bound the mutant protease with low affinity 
were sequenced and identified. The subsequent sections of this chapter will introduce 
some of the relevant topics in more detail. 
 
1.2 Inteins 
Inteins are naturally occurring in frame protein fusions that can self splice out, 
ligating together the extein sequences of the gene in which they occur. They are very 
similar to the group I self splicing introns which splice at the RNA level [27]. Inteins 
since their first description in yeast Saccharomyces cerevisiae [28, 29],  have now 
been identified in all three kingdoms of life, as well as in bacteriophages. Many of the 
inteins like the group I introns are mobile at the genetic level because they code for 
homing endonucleases [27]. Upto 70% of the inteins identified are found in genes that 
are related to DNA metabolism including DNA polymerases, helicases and gyrases 
[27], which often are vital genes to the organism [30]. Although inteins have been 
denoted as selfish genes, because no known function exists for many of them, some 
experiments have suggested that they might hold regulatory roles in cells, and that 
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ancestral inteins might have had some function but they were lost during evolution 
[27, 30].  
 
1.2.1 Mechanism of protein splicing  
The mechanism of protein splicing has been well studied by many groups [31-33]. 
There are several key residues involved in protein splicing. The first amino acid of N-
intein (see Figure 1) is invariably a cysteine or a serine residue. The thiol or the 
hydroxyl side chains of these amino acids undergo an acyl shift at the N-terminal 
splice junction. The first residue of C-extein is invariably a cysteine or threonine or 
serine. The side chains of these are equipped to attack the electrophilic N-terminal 
splice junction, resulting in a branched intermediate. An asparagine residue precedes 
the C-terminal splice junction, and helps in resolving the intermediate through 
cyclization and succinimide formation. Eventually an S-N acyl shift releases the 
spliced product. 
1.2.2  Engineered inteins in biotechnological applications  
Intein splicing does not require cofactors and the process of splicing is very efficient 
[34]. The novelty of inteins, ever since their discovery, has been exploited for a 
variety of biotechnological applications, ranging from synthesizing toxic proteins (by 
expressing them in two parts in the cell and ligating them externally using the intein- 
mediated method to give the native peptide bond [35]), cyclization of proteins and 
peptides [36], attaching novel functionalities to proteins site specifically [6-11], 





Figure 1: The steps involved in the self splicing of inteins, see text for details. 




[38, 39]. NEB has commercialized vectors that enable the cloning of desired genes 
with an intein either at the N/C-terminus and a CBD tag. Upon expression and affinity 
column purification, the protein of interest can be cleaved off by inducing intein 
cleavage under some specified conditions [31]. The inteins that can splice out 
conditionally were engineered from the native counterparts through a combination of 
both rational engineering and directed evolution approaches [40-42]. These inteins 
were designed such that they splice out only from either N/C-terminus, and they were 
pH or thiol agent inducible [40-42].  
 
1.2.3  The intein based method to tag proteins site-specifically  
Protein microarray is emerging as a powerful tool in the high throughput analysis of 
protein abundance and function [43-45]. One of the key concerns in the fabrication of 
functional protein microarrays is the method of immobilization, which to some extent 
determines whether or not a protein retains its function [46]. There are two obvious 
choices, either random immobilization or methods that allow site-specific uniform 
orientation. Both of these methods have been used to develop protein microarrays 
[47].  In this report a strategy for the immobilization of proteins onto a microarray site 
specifically via the N-terminus was developed.  For the N-terminal immobilization, 
the chosen model proteins were cloned onto a vector system that facilitates the 
expression of the protein with an N-terminal intein fusion. An extra cysteine residue 
was introduced at the junction of the intein and protein fusion. Upon expression of the 
intein-protein fusion, intein splices out, leaving the protein with an N-terminal 
cysteine [6]. N-terminal cysteine containing EGFP was produced in this manner and 
successfully immobilized onto thioester glass surface. Also as a complementary 
approach to the N-terminal immobilization, immobilizing proteins expressed from a 
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yeast host, via a C-terminus biotin moiety onto avidin-functionalized microarrays was 
considered. Three different inteins available from NEB, were fused individually to the 
C-terminus of the EGFP, and expressed in a suitable yeast expression system. The 
expression levels and the in vivo cleavage pattern of the three inteins were analyzed. 
One of the three inteins, the Sce VMA Intein was found to express better than the 
other fusions and the in vivo cleavage of the fusion was minimal. Hence the Sce VMA 
Intein fusion was chosen for further studies. Fusion to intein at the C-terminus allows 
the production of thioester functionality at the C-terminus, which in turn can react 
with the sulfhydryl moiety of the cysteine in cysteine-biotin, to give a C-terminal 
biotinylated protein via a native peptide bond. Using this, a model protein EGFP was 
biotinylated and the immobilization efficiency onto to an avidin microarray was 
evaluated. Once the system was established it was foreseen that important enzymes 
present in the yeast, namely the kinases, phosphatases and proteases, could be 
immobilized in a high-throughput fashion using this method. Then they could be 
studied in a parallel fashion using the available activity based fluorescent probes in 
our lab [23-26]. 
 
1.3 Phage display  
Bacteriophages are virus that feed on bacteria. They have a simple structure with their 
nucleic acid genome surrounded by a coat of proteins [50]. There are two kinds of 
bacteriophages, the lytic ones and the nonlytic ones [51]. For many years 
bacteriophage genomes have traditionally been used as vehicles of gene transfer to 
bacteria [51, 52]. The concept of phage display was introduced by George P Smith, 
who came up with a method to display foreign peptides on the surface of the 
bacteriophage M13, through a fusion to its coat protein Gene III [53]. Product of Gene 
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III resides on the tip of the filamentous bacteriophage and is involved in infection of 
the host bacterium. He found that small peptides fused to the N-terminus of the Gene 
III can be displayed on the phage tip without interference to its infective capacity 
[53]. He called his method phage display and demonstrated its first application in 
mapping epitopes of antigens [54]. Ever since, peptides and proteins have been 
successfully displayed on phage and a collection of phage display vectors are now 
commercially available [52].  
 
Typically the protein/peptide of interest is cloned into either bacteriophage 
genome/phagemids using traditional cloning methods. The most commonly used 
phage is the M13 phage. There are two different genes that are typically used for the 
display of peptides and proteins on M13. One is the gene III, this is present in up to 5 
copies on the tip of the virion. Gene VIII is another available display protein system, 
it is present in up to 2700 copies per virion. Due to steric limits only small peptides 
are tolerated in the latter system. The Gene III system can tolerate proteins up to 
100kDa [3], but the number of copies displayed on each virion should be limited as 
the protein gets larger [55]. This is done by cloning the protein of interest into a 
phagemid rather than into the phage genome itself, and then rescuing the phagemid (a 
phagemid is a plasmid with phage origin of replication; when F+ cells, harboring such 
phagemids are infected by a helper phage, the phagemid gets replicated from the 
phage origin and packaged into the phage heads preferentially over the helper phage 
genome) using helper phages (phages whose genomes contain impaired origin of 
replications). When using the phagemid method to display proteins, depending on the 
size of the protein and how well it is tolerated on the phage, the number of copies of 
the displayed protein can vary from 0-5 per phage.
10 
Figure 2: The intein mediated strategy to Biotinylate proteins on the C-terminus. Intein is fused to the C-terminus of the desired protein using recombinant 
DNA methods. Upon protein expression, the fusion protein is pulled down onto chitin beads. When incubated with MESNA (a thiol reagent that induces 
splicing of intein), the sulfydryl group of Cys-Biotin attacks the thioester intermediate that is formed at the C-Terminus of the protein to give a covalent 
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1.3.1 Applications of phage display  
Using the method described above, libraries of peptides or proteins can be displayed 
on the phage giving rise to a number of applications [55]. The phage can be then 
viewed as a huge bead with a protein/peptide of interest tethered to it. The genetic 
information of the protein/peptide resides inside the phage and is retrievable any time 
by a simple sequencing step. As such the phage then is a coded, amplifiable and 
infinitely storable bead. In the affinity selection method, the protein of interest is 
coated onto a solid surface and the phages bearing the random peptide libraries are 
applied to it. After incubation, the non binders are washed off, and the binders are 
eluted by nonspecific methods that disrupt protein-protein interaction (e.g. glycine at 
pH2.2, the phages themselves are extremely robust and can withstand harsh chemical 
conditions) or by the use of a known competing ligand (see Figure 3). Then the 
binders are amplified and enriched, before going through another round of selection. 
The selection rounds are repeated until significant binders emerge. The binders are 
identified through DNA sequencing. Typically a consensus sequence emerges (a 
group of binders with similar sequences).  
 
To cite a few interesting examples, using the method of affinity selection, a number of 
cloned SH3 domains were used to select ligands from a random peptide library. Upon 
identification of the ligands, these were used to probe conventional cDNA libraries 
for protein that bind to the identified ligands. In this manner 18 homologs of the SH3 
domain were identified, several of them previously unknown [63-65]. A peptide 
mimic of the natural protein hormone erythropoietin [66] has been identified using 
this method. L-amino acid peptide ligands for the D-amino acid isoform of the SH3 
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domain have been selected. The D-version of the L-peptides, then are ligands for the 
natural SH3 protein [67].  
 
Proteolysis is a common form of posttranslational modification and is important in 
several biological cascades and signaling pathways [68]. Knowledge of protease 
specificity allows us to design better inhibitors, identify biologically relevant 
substrates and is useful in applying proteases in site-specific proteolysis. Substrate 
characterization of a protease is a time consuming step with traditional methods, 
which involve scanning of peptide libraries or deriving substrates from physiological 
substrates. After the introduction of phage display by Smith and colleagues, a method 
called “substrate phage” came into use for the discovery of substrates of proteases 
[69-75]. In this method, random peptide libraries which represent potential substrates 
of a protease are displayed on the surface of the phage. One end of the substrate is 
tethered to the phage while the other end is fused to any convenient affinity domain. 
Following immobilization of the substrate phages on the affinity support, the phage is 
incubated with the protease whose substrate specificity is to be determined. Only 
potential substrates will be released, which can then be amplified to increase their 
number and subjected to further rounds until good substrates emerge.  
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Figure 3: General scheme for affinity base
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1.3.2 Enzyme evolution on phage 
Enzymes have been displayed on the surface of phages in order to be evolved into 
more active, or more stable counterparts or into mutants recognizing different 
susbstrates [3-5, 76]. Evolution of enzymes on phage, apart from the requirement of 
active display on the phage also requires a good selection scheme which can select for 
the active members from the library of mutants displayed on the phage. To date, 
several such selection strategies have been employed to evolve enzymes on phage 
[77-86].  
 
One very interesting selection scheme is the product capture approach. This was 
introduced simultaneously and independently by two different groups [81, 82]. The 
enzyme is displayed on the phage, and alongside the enzyme the substrate is displayed 
in close proximity (either chemically ligated to the surface coat proteins of the phage 
[82], or ligated by means of electrostatic interaction, followed by a chemical crosslink 
[81]). Thus the substrate is accessible to the enzyme active site, now active enzymes 
are able to convert substrate to product.  The next step is product-capture and it 
involves capture of the reaction product by a product-specific reagent or antibody. In 
this report a selection scheme for the evolution of active mutants of SrtA on phage has 
been devised.  
 
1.3.2.1  Developing a strategy to evolve SrtA on T7 phage 
SrtA is one of the homologs of the transpeptidase Sortase discovered in gram positive 
bacteria [87]. It catalyses a transpeptidation reaction that anchors proteins important 
for the pathogenesis of gram positive bacteria to their cell wall [88]. The crystal 
structure of SrtA has been solved [89]. The sorting mechanism has been well studied 
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[90-96]. Proteins bearing the signature motif LPETG (a 5 mer peptide)  are cleaved by 
SrtA between T and G and ligated to N-terminal glycine containing peptidoglycan 
building unit. Thus proteins that are important for the pathogenesis are sorted and 
attached onto the cell wall covalently. It has been proposed that SrtA might be a good 
drug target against gram positive bacteria [97]. The protein has been purified, with its 
membrane anchor removed [98], (N terminal 60 amino acids) and its kinetics has been 
well studied [99]. According to a HPLC assay the kinetic parameters have been 
established as Km = 5.5 mM for the LPETG substrate and 140 µM for the glycine 
substrate [99]. It has been shown that Gn, n = 1 to 5 can be used as nucleophilic 
substrate mimic of SrtA. Sortase has also been viewed as an attractive target enzyme 
to carry out modifications of proteins [100] such as ligating specific tags to the 
terminus of a protein [13], and as a self cleavable affinity tag for affinity purification 
of proteins [101].  
 
Here in this project it was hypothesized that SrtA could be used to ligate fluorescent 
probes to proteins engineered to have a LPETG motif, and ultimately be useful for 
imaging proteins in live cells. To this end it was shown that EGFP protein expressed 
with a LPETG motif at its C-terminus could be successfully ligated with GG-TMR. 
Fluorescent probes were designed to study the hydrolysis and transpeptidation activity 
(see Figure 4).  Although SrtA has been proven to be a very robust enzyme inside the 
cell (can sort proteins within min inside the cells [88]) it is not very active in vitro 
with a modest Kcat of 0.27/sec [99]. Upon transferring SrtA into the mammalian cell 
the activity of SrtA which has a bacterial origin might not be optimal. Hence it was 
decided to evolve SrtA into a much more active enzyme. With this goal in mind and 






































Figure 4: Hydrolysis and transpeptidation activity of SrtA. To detect the hydrolysis 
activity of SrtA, it was incubated with a quenched fluorescent substrate (ACC-
LPETG-DABCYL), upon cleavage of the T-G bond, the fluorescence of ACC is 
released. SrtA solely catalyses a transpeptidation activity in the presence of a 
nucleophilic GG-substrate, thus when incubated with the quenched fluorescent 
substrate and GG-peptide, SrtA mediates the transfer of GG-peptide to the substrate 














Figure 6: Self-ligation of G5-BIOTIN substrates onto C-SrtA. The substrate LPETG 
was fused to the C-terminus of SrtA (C-SrtA). Upon incubation with the penta-
glycine substrate conjugated to biotin, SrtA is able to self-ligate the biotin substrate 





we decided to display mutants of SrtA on the surface of phage, and select for active 
members using a self ligation scheme (see Figure 5). In the self ligation scheme the 
N- or C-terminus of SrtA is extended to include the corresponding substrates of SrtA 
(SrtA as mentioned previously needs two substrates, a LPXTG peptide and NH2-Gn =1-
5 with the NH2 termini free for nucleophilic attack). Accordingly the LP(X=E)TG –
COOH substrate was fused to the C-terminus of SrtA, which will be called C-SrtA, a  
NH2-(GGGSE)3  substrate was fused to the N-terminus of SrtA, which will be called 
N-SrtA (see Figures 6 and 7). Substrate fusion on SrtA was done and the activity and 
self-ligation ability of SrtA was tested. It was shown successfully that the concept of 
self-ligation worked on free SrtA on both the display systems.  
 
Following this the N-SrtA and C-SrtA were displayed on phage and the activity was 
tested. Display on the M13 phage allows the N-terminus of the displayed protein to be 
free. Display on the T7 phage allows the C-terminus of the displayed protein to be 
free. For display onto the M13 phage, SrtA was fused to the N-terminus of gene III. 
To display proteins on the T7 phage, SrtA was fused to the C-terminus of the capsid 
gene10B. While we could conclusively see that the SrtA on T7 phage was active after 
display, we failed to prove activity of SrtA on the M13 phage. Following this all 
experiments used the T7 phage system only. C-SrtA-T7 could be successfully 
affinity-purified from a pool of non-SrtA phages. Additionally, for the selection 
system to work, it was required to prove that the self-ligation assay works on the 
phage as well. Towards this end, we proved that SrtA on T7 phage could successfully 
carry out the self-ligation of GG-TMR onto itself (see Figure 8). Thus a selection  
18 











 phage  
Active members 
 ligate  
substrate onto 
themselves 
A mutant library of  




 are pulled down  
via the HIS tag 
Incubated with  
GG-Biotin  
bound SA beads 
The active members 


























method was successfully designed, with which one may be able to select in future, 
from a pool of random mutants of SrtA, the active members. 
 
1.3.3 Affinity selection of binders against 3CL protease mutant from SARS 
The SARS coronavirus, the causative agent of Severe Acute Respiratory Syndrome 
[103], was sequenced and revealed to have 2 overlapping poly-proteins [104]. A 3C 
like protease encoded in the poly-protein was involved in cleaving the poly-protein to 
generate functional proteins responsible for the replication of the virus. Based on the 
sequences of the different strains of the SARS virus sequenced, the 3CL protease was 
highly conserved and it also shared homology with main proteases from other 
coronavirus [105]. The protein has been cloned and purified [106] and its 3D structure 
has been solved [107]. The cleavage preference of the protease lies in the P1, P2, and 
P1’ residues. It prefers a glutamine in the P1 position, hydrophobic residue in the P2 
position and alanine, serine or glycine residue in the P1’ residue [106]. Given the fact 
that this is an important protease in the life cycle of the virus, the 3CL protease was 
considered to be an important drug target for SARS. A small molecule library, which 
also included some current drugs in the market (based on molecular simulation 
experiments these had previously been proposed to be inhibitors of the virus) was 
screened against the virus.  Most of the predicted drugs had no effect on the virus, 
while some others from the library did show inhibition [100]. Given the fact that the 
3CL protease was considered  an important drug target and due to the paucity of the 


















Figure 7: Self-ligation of biotin-LPETG substrates onto N-SrtA. The substrate 
(GGGSE)3 was fused to the N-terminus of SrtA (N-SrtA). Upon incubation with the 
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Figure 8: Self ligation of G2-TMR substrates onto the C-SrtA displayed on the T7 
phage. C-SrtA was displayed on the surface of T7 phage. Upon incubation with the 
di-glycine substrate conjugated to the fluorescent dye TMR, SrtA on phage is able to 









It was decided to mutate the active site of the enzyme 3CL and select for good binders 
from a commercially available peptide phage display library. While incubation with 
the active enzyme will cleave most of the binders, incubation with the mutant will 
enable isolation of binders. Upon emergence of a strong binder a group of similar 
peptides may then be designed, synthesized and the inhibition of the protease can be 
studied in solution. In this report, a commercially available 7 amino acid peptide 
library on the phage was used to screen against the active site mutant of the 3CL 
protease in efforts to identify good peptide binders to the enzyme (see Figure 3). All 
assay procedures was optimized using Streptavidin as a model protein. Using the 
affinity selection method, multiple rounds of the library selection were carried out. 
This was followed by a binding assay to select for good binders. Several low affinity 















2. MATERIALS AND METHODS  
 
 
2.1  Making chemically competent bacteria for transformation 
The desired bacterial strain was grown until OD600 reached 0.5 and chilled on ice for 
15 min. The cells were harvested at 1681g, 4 °C, for 10 min. 0.5 volumes (of the 
starting volume of culture) buffer A was added and the pellet was resuspended by 
pipetting up and down. After 15 min of incubation on ice, the cells were harvested 
again as above. The pellet was resuspended in 0.04 volumes (of the starting volume of 
culture) of buffer B, incubated on ice for 15 min. The cells were then aliquoted into 
100 µL aliquots, frozen by placing in liquid nitrogen, and placed immediately at -
80°C. Competency in the orders of 107/µg of plasmid DNA was obtained using this 
protocol. For all buffer compositions see appendix A. 
 
2.2  Transformation of plasmids/ligated vectors into chemically competent 
cells 
The competent cells were thawed on ice. The DNA (plasmid/ligated vector) was 
added into the competent cells (the volume of the DNA sample did not exceed 5 % of 
the volume of the competent cells). Typically 100 µl of competent cells was used per 
transformation reaction. The tube was gently tapped to allow mixing of the DNA with 
the cells. This mixture was then incubated for 30 min on ice. A heat shock at 42 °C 
was given to the cells, for 45 sec. LB media was added (the volume of the mixture 
was topped up to 500µL with LB) and the cells then incubated at 37 °C, 250 rpm, for 
1 hr (for the recovery of the cells from the heat shock and expression of the antibiotic 
resistance genes). Following this, the cells were either split and plated (100 µl and 
400 µl) or all 500 µl was plated, based on the number of colonies expected, on the 
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appropriate LB/antibiotic plates, left to grow O/N at 37 °C until colonies were visible.
   
2.3  Transformation of yeast cells 
The yeast strain InvSC1 (INVITROGEN) was used to make competent cells using the 
S.c. EasyComp. Kit™ obtained from Invitrogen. The preparation of the competent 
cells and transformation was done according to the company protocol.  
 
 2.4  PCR  
 
All PCR’s in this thesis, unless otherwise stated, contained the following, in the PCR 
master mix: 0.2 mM dNTP mixture, 10-50 ng of template DNA, 0.1 µM of each 
primer and 2.5 U DNA polymerase* in the corresponding polymerase buffer. The 
PCR program consisted of the following,  15 min , 95 °C;  29 cycles of  30 sec, 95 °C, 
X ŧ sec, X° ŧ C, X ŧ min, 72 °C; with a final  10 min 72 °C extension. For primers used 
in various cloning experiments please refer to Cloning Table, Appendix B. *Taq 
polymerase (Promega) was used for screening (e.g. colony PCR) and optimizing PCR 
conditions. *Hot Star Taq polymerase (QIAGEN) was used when cloning was 
intended. *Pwo polymerase (Roche) was used when full length amplification of 
plasmid DNA was desired. ŧAnnealing temperature was typically set 5 °C less than the 
lowest Tm of the two primers; ŧannealing time varied in between 30 sec to 1 min, and 
ŧtime of extension was 1kB/min for Taq polymerase. All PCRs were performed in the 







2.5 Cloning  
2.5.1 TA cloning  
The pCR®2.1-TOPO® ( Invitrogen) vector was used for all TA cloning procedures. 
After PCR amplification of the desired gene, an agarose gel was run to check the 
yields. If the yield of the PCR product was acceptable (20-40 ng/µL) a 1/3rd reaction 
volume of that recommended by the company protocol was set up and found to be 
sufficient to give significant number of colonies. Typically 1.33 µL of the PCR 
product was combined with 0.33 µL of the salt solution and 0.33 µL of the TOPO 
vector, incubated at RT for 30 min. Following incubation the entire reaction mix was 
transformed into chemically competent TOP10 cells (Invitrogen) and plated onto X-




2.5.2 Gateway cloning 
 
To clone genes into gateway destination vectors, primers were designed that flank the 
gene of interest, and also carry the necessary recombination sites (AttB) required for 
the recombination reaction. See Cloning table, Appendix B, for all primers. After the 
production of the AttB-PCR products, a BP cloning was set up. Normally 1/8th of the 
reaction volume recommended by the manufacturer (Invitrogen) was found to be 
sufficient for a BP reaction (see Figure 9). A 1/8th BP reaction typically contained 5-
15 fmol of the attB PCR product, pDONR™ vector (pDONOR201) ~20 ng, 0.5 µL -1 
µL of the BP Clonase™ mix, 0.5 µL of the 5 X reaction buffer and TE (10 mM Tris 
and 1 mM EDTA, pH 8) to 4 µL. The reaction mix was incubated at 25 °C for 12 hrs. 








Figure 9: The BP cloning reaction.  Facilitates recombination of an attB substrate 
(attB-PCR product or a linearized attB expression clone) with an attP substrate (donor 
vector) to create an attL-containing entry clone. This reaction is catalyzed by BP 
Clonase™ enzyme mix. (Figure and caption are taken from Gateway® Technology, 












Figure 10: The LR cloning reaction  Facilitates recombination of an attL substrate 
(entry clone) with an attR substrate (destination vector) to create an attB-containing 
expression clone. This reaction is catalyzed by LR Clonase™ enzyme mix.(Figure 








continued at 37 °C. The entire mix was used for transformation into TOP10 cells. BP 
recombinants were identified using a PCR screen with appropriate primers and sent 
for DNA sequencing. Upon verification of the sequence, the BP construct was ready 
for a LR reaction. One fourth of the reaction volume recommended by the 
manufacturer (Invitrogen) was found to be sufficient for a LR reaction (see Figure 
10). A ¼th LR reaction typically contained 75 ng of the entry clone, 75 ng of the 
destination vector, 0.5 µL of the LR clonase™ mix, 1 µL of the 5X reaction buffer 
and TE (10 mM Tris and 1 mM EDTA, pH 8) to 5 µL. The reaction mix was 
incubated at 25 °C for 12 hrs. Following this 0.4 µl of Proteinase K solution was 
added to it (supplied with the kit) and incubated for 10 min at 37 °C. The entire mix 
was used for transformation into TOP10 cells. Upon PCR verification of LR 
recombinants, the LR construct was transformed into the suitable expression host.  
 
2.5.3 RE-based cloning into conventional plasmids and large bacteriophage 
genomes 
To clone genes into conventional plasmids, the following procedures were used. The 
desired genes were PCR amplified (for primers used in the cloning of different genes 
see cloning Table, Appendix B), cloned into the pCR®2.1-TOPO® and sequence 
verified. Following this the clone was digested at the designed enzyme sites (enzyme 
sites were normally added onto the primers, for details see Cloning Table, Appendix 
B) and gel purified using the QIAquick gel extraction kit™ (Invitrogen). The gene thus 
prepared was ligated into appropriate vectors (vector was linearized using the same 
enzymes, purified using the QIAquick gel extraction kit™ (Invitrogen), de-
phosphorylated using Shrimp Alkaline phosphatase (Promega) and purified again 
using the QIAquick PCR purification kit™) using the T4 DNA Ligase (Promega). To 
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clone into huge bacteriophage genomes, the procedures for preparation of the insert 
gene remained the same as above (see Figure 11). The 10-3-B T7 DNA was extracted 
as per the protocol from the Lambda Mini purification kit (Qiagen). Buffer L1 from 
the kit contained RNAse and DNAse, which were found to degrade in a few months 
after the kit was opened. Because of this the extracted DNA was found to contain 
huge smears when run on the gel to check for purity. Addition of RNAase (0.3 mg/10 
mL lysate) and DNAase (90 µg/10 mL lysate) to the clarified lysate before incubation 
at 37 °C with buffer L1 (Step 1 of the protocol), and also an additional proteinase K 
treatment (0.2 mg/mL) during step 6, solved this problem. While the digestion of the 
T7 vector DNA followed conventional restriction enzyme digestion procedures, 
purification of large fragments of DNA (greater than 10 kB, e.g.,  the 37 kB, 10-3-B 
vector from Novagen) using the regular commercial gel/ PCR purification kits was 
extremely inefficient. Hence several other alternatives were considered. The only 
purification system that has given the highest yields is Agarase (available from 
several sellers, NEB, Fermentas etc...) enzyme digestion of the agarose gel (efficient , 
greater than 90% yields), followed by ethanol precipitation of the DNA. But it was 
found that packaging (see Section 2.16.1) of the ligated DNA into the T7 packaging 
extract (Novagen) is severely impaired when the DNA was purified using agarase 
(presumably the carbohydrate moieties that are left over from digestion of the agarase 
gel, precipitates during ethanol precipitation and affects the packaging reaction). 
Yields upto 30% was obtained after gel purification of large DNA using the QiaExII 
beads from Qiagen. But for regular cloning purposes, when purification was intended, 
a simple ethanol precipitation of DNA [52] was sufficient. The small DNA fragment 
resulting from the digestion of the vector will not be precipitated very efficiently, and 
not interfere with the cloning.  Since large DNA fragments are susceptible to shearing 
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from vigorous pipetting, when possible large bore tips and gentle pipetting was used. 
Separation of large fragments of DNA (the 20 kB and the 17 kB fragment obtained 
after digestion of 10-3-B) was done by running the fragments in a 0.4 % agarase gel, 
at 15 V, for greater than 6 hours up to O/N. For further information on the different 
genes that were cloned and the different vector back bones used please refer to 
Cloning Table, Appendix B. 
 
2.6 Sequencing of genes 
All genes were sequenced using the ½ reaction recommended by the ABI prism 
manual. BIG dye V3.1 (ABI), was used and the genes were sequenced using the ABI 
3100A sequencer. A typical sequencing PCR mix contained the following, 100-150 
ng of Template DNA, 4 µL of the BIG dye reaction mix (with polymerase and 
ddNTPs) 3.2 pmoles of each primer, 2 µL of the 5X reaction buffer in a total of 20 µL 
reaction volume, and subjected to the following PCR program, 24 cycles of 96 °C, 30 
sec; 50 °C, 15 sec; 60 °C, 4 min. 
 
2.7  Site directed mutagenesis of genes  
Site directed mutagenesis of genes was carried out by designing the mutation 
(typically one to two base pair substitutions) into a forward primer that flanks the 
mutation by 20-25 base pairs on either side of the mismatch. The reverse primer was 
the exact complement of the forward primer. PCR of the whole plasmid was then 
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introduced into the template using the primers during the PCR reaction, following 
which the parental strand without the mutation was digested away. Specific digestion 
of the parental strand was effected using the enzyme DpnI which cleaves away the 
methylated strand of the parental DNA (see Figure 12). Either the Pfu Turbo 
polymerase (Stratagene), or the Pwo polymerase (Roche) was used. When Pfu Turbo 
polymerase was used, the PCR reaction conditions were similar to the instruction 
protocol (QuikChange site directed mutagenesis kit from Stratagene). When the 
whole plasmid template PCR was carried out using the Pwo polymerase (Roche), the 
PCR reaction mix contained the following. 5 U of the Pwo polymerase, 600 pM of 
each primer , 0.2 mM each dNTP, 50-100 ng of template, in a 50 µL reaction, using 
the following program, 94 °C, 2 min; 10 cycles of  94 °C 15 sec; 55 °C, 30 sec; 6 min, 
72 °C and 15 cycles of 94 °C, 15 sec; 55 °C, 30 sec; 6 min + 20 sec/Cycle (cycle 
extension) 72 °C, with a final  10 min, 72 °C extension. Following PCR the parental 
template was digested using DpnI (NEB) and transformed into XL1blue cells. The 
transformants were DNA sequence verified. For further information on the different 
genes that were mutated and the different primers used please refer to Cloning table, 
Appendix B. 
 
2.8  Expression of different fusion proteins from different vectors and hosts. 
For details of expression conditions for each Clone/Host pair, see Expression table, 
Appendix B. All bacterial hosts were grown in LB media prior to and during 
induction of protein expression. Following expression of proteins, the bacterial cells 
were harvested at 1681g, 4 °C, for 15 min, and the pellets were frozen at -20 °C.  
Details of expression of genes from yeast are as follows. Yeast cells (InvSC1, 





Figure 12: Overview of the site directed mutagenesis method. Figure adapted from 





(see appendix for composition). An overnight culture of yeast cells (5 mL) was grown 
and the OD600 was measured. A volume of cells needed to give OD600 = 0.4 in 5 mL 
of SD-URA + 2 % galactose (Induction media) media was calculated and the same 
was added to the induction media. The cells were grown for another 24 hrs and 
samples were removed at various time intervals (2, 4, 6, 12, 24 hrs), to check for 
expression levels and frozen O/N at -20 °C.  
 
2.9 Western blot of proteins 
Western blot protocol that used penta-HIS antibody for detection of 6XHIS-tagged 
proteins is given below. Proteins (pure protein/crude cell lysate) to be detected using a 
penta-HIS-HRP conjugated antibody, were denatured and run on a SDS –PAGE gel. 
Transfer of the proteins from the gel to a solid support (PVDF, Amersham) was done 
using either semi dry transfer method (HOEFER TE 70, Amersham) when the 
proteins where small (up to 50 kDa) and using the wet transfer method (Mini trans 
Blot electrophoretic transfer unit, Biorad) when the proteins were larger than 50 kDa. 
The transfer was done following manufacturers instructions. Following transfer, the 
membrane was blocked using 5 % skimmed milk dissolved in PBST (Tween 20, 
0.1%) either O/N at 4 °C or for 1 hr at RT. Penta HIS HRP conjugate antibody 
(QIAGEN) was then added at a 1 in 1000 dilution in 5 % skimmed milk dissolved in 
PBST (Tween 20, 0.1%) to the membrane and incubated for 1 hr at RT. Milk is 
known to reduce the sensitivity of the anti-HIS antibody (penta-HIS-HRP-conjugate, 
QIAGEN), and was used only when substantial amounts of protein was expected to be 
transferred onto the blot. Following this the membrane was washed 6 times, with 
buffer changes after every 10 min in PBST (Tween 20, 0.1 %) using a suitable shaker. 
The HRP signal was then visualized using  ECL plus (Amersham pharmacia biotech) 
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or Super Signal® west Pico/Dura substrate (Pierce), depending on the amounts of 
protein expected to be transferred. Likewise for more details on dilution ranges, 
incubation time, wash conditions of other antibodies used to detect other affinity tags 
please refer to Expression table, Appendix B.  
 
2.10 Affinity chromatography of proteins  
 
2.10.1 Ni-NTA column 
The 6X-HIS tagged proteins were purified using Ni-NTA resin (QIAGEN). The 
frozen pellets (see Section 2.8) were thawed on ice, lysis buffer H1 (for all buffers see 
Appendix A) was added followed by addition of Lysozyme (Sigma) at 1 mg/mL and 
incubation was continued on ice for 30 min.  The volume of lysis buffer H1 added 
depended on the expression level of the protein. If the expected yields of protein were 
less the 1 mg/liter of culture then a 100X concentration was used, e.g., 50 mL starting 
culture volume was concentrated to 0.5 mL lysis buffer. The cells were sonicated for 
further lysis. Sonication was carried out with 30% amplitude, 10 sec ON, 10 sec OFF, 
12 times, using the SONICS™ ( Newtown, CT, USA) VIBRA CELL. Successful lysis 
of cells was followed by using a Bio-Rad-Protein assay (BIORAD) which was carried 
out according to manufacturer’s instructions. The micro-assay procedure was used. 
The lysed cells were then centrifuged at 20,598g for 30 min at 4 °C. The supernatant 
was incubated with 100 µL Ni-NTA™ beads / 100 mL culture, for 1 hr at 4 °C. The 
6XHIS tagged proteins were separated from other unbound proteins by washing at 
first with 10 bed volumes of wash buffer H2, followed by wash with 10 bed volumes 
wash buffer H3. Elution of the 6XHIS tagged proteins was done by the addition of 
elution buffer H4. Elution of the proteins was monitored using the Bio-Rad protein 
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assay. The fractions containing substantial amounts of proteins were pooled and 
napped using the NAP™ columns (Pharmacia Biotech)  into buffer H5, aliquoted into 
“use and throw” volumes and frozen at  -20 °C. Proteins were napped according to 
manufacturer’s instructions, using the NAP™ -5 columns. 
 
2.10.2 GSH column 
The GST tagged proteins were purified using GSH resin (Amersham). The frozen 
pellets (see Section 2.8) were thawed on ice, lysis buffer G1 (for all buffers see 
Appendix A) was added followed by the addition of Lysozyme (Sigma) at 1 mg/mL 
and incubation was continued on ice for 30 min.  A 20X concentration was 
performed, e.g. 200 mL starting culture volume is concentrated to 10 mL lysis buffer. 
The cells were sonicated for further lysis. Sonication was carried out with 30 % 
amplitude, 10 sec ON, 10 sec OFF, 12 times, using the SONICS™ ( Newtown, CT, 
USA) VIBRA CELL. Successful lysis of cells was followed by using a Bio-Rad-
Protein assay (BIORAD) which was carried out according to manufacturer’s 
instructions. The micro-assay procedure was used in all cases. The lysed cells were 
then centrifuged at 20,598g for 30 min at 4 °C. The supernatant was incubated with 
500 µL GSH beads / 100 mL culture, for 30 min at RT. The GST tagged proteins 
were separated from other unbound proteins by washing at with 10 bed volumes of 
wash buffer G2. Elution of the GST tagged proteins was done by the addition of 
elution buffer G3. Elution of the proteins was monitored using the Bio-Rad protein 
assay. The fractions containing substantial amounts of proteins were pooled and 
napped using the NAP™ columns (Pharmacia Biotech) into buffer G4, aliquoted into 
“use and throw volumes” and frozen at -20 °C. Proteins were napped according to 
manufacturer’s instructions, using the NAP™ -5 columns. 
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2.10.3 Chitin columns  
The CBD (chitin binding domain) tagged proteins were purified using Chitin beads  
(NEB). After expression of proteins in yeast (5 ml), the cells were harvested and 
frozen O/N at -20 °C. The cells were allowed to thaw on ice and lysis buffer C1, 0.5 
ml, was added (a 10X concentration was used). The cells were sonicated for lysis. 30 
% amplitude, 30 sec ON, 30 sec OFF, a total of 7 min ON and SONICS™ (Newtown, 
CT, USA) VIBRA CELL was used. Following this the lysate was checked for 
fluorescence using the Typhoon 9200 (Amersham -Biosciences) at the EGFP 
fluorescence wavelength. The lysate was spun down at 20,598g for 30 min at 4 °C. 
The supernatant was incubated with 25 µL Chitin beads / 5 mL culture, for 30 min at 
RT. The CBD tagged proteins were separated from other unbound proteins by 
washing with 10 bed volumes of wash buffer C2. Purification was checked by boiling 
the beads and running them on a SDS-PAGE gel.  
 
2.11 Production of N-terminal cysteine proteins 
The cells harboring the respective plasmids were grown in 1 L of LB medium 
containing 100 mg/L ampicillin at 37 °C in a 250 rpm air shaker.  Protein expression 
was induced at OD600 ~ 0.6 with 0.5 mM IPTG and left shaking O/N at RT.  Cells 
were harvested by centrifugation (5000g, 30 min, 4 °C), resuspended in lysis buffer 
(20 mM Tris-HCL pH 8.5, 500 mM NaCL, 1 mM EDTA) and lysed by sonication on 
ice.  The cell debris was pelleted down by centrifugation (4000g, 30 min, 4 °C) to 
give a clear lysate containing the intein-fusion proteins.  A column packed with 10 
mL of chitin beads was pre-equilibrated with column buffer (20 mM Tris-HCL pH 
8.5, 500 mM NaCL, 1 mM EDTA).  The clear lysate was loaded onto the column at a 
flow rate of 0.5 mL/min and washed with 10 volumes of column buffer.  The column 
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was then flushed quickly with one column volume of cleavage buffer (20 mM Tris-
HCL pH 7.0, 500 mM NaCL, 1 mM EDTA) before stopping the flow.  The above 
procedures were carried out at 4 °C to prevent premature on-column cleavage of 
intein-tag. On-column incubation with the cleavage buffer took place for 20 hr at RT 
with gentle agitation and the protein was eluted in 2 mL fractions.   
 
2.12 Spotting of N-terminal cysteine proteins on thioester slides 
Thioester slides were prepared as follows. The epoxy-derivatized slides (see Section 
2.14) were incubated with 10 mM diamine-PEG for 30 min. The slides were then 
washed with deionized water and placed in a solution of 180 mM succinic anhydride 
for 30 min. This was followed by boiling the slides in water for 2 min. NHS solution 
was prepared and the slides were incubated with it for 3 hr. Following incubation the 
slides were rinsed with deionized water and allowed to react O/N with a solution of 
benzylmercaptan. Finally, the slides were washed with deionized water and dried. 10 
µL of the clarified cell lysate (see Section 2.11) was added on to a source plate. The 
N-terminal cysteine-containing proteins were adjusted to a stock concentration of 1 
mg/mL (with PBS buffer, pH 7.4).  Stocks with series dilutions were also prepared.  
The protein was spotted onto the thioester-functionalized glass slides using an ESI 
SMA™ arrayer. All slides were incubated for 3 hrs and subsequently washed with 
water for 20 min, followed by detection or storage at 4 ºC.  For detection of protein 
immobilization, slides were scanned with an ArrayWoRx™ either directly under 





2.13  In vitro biotinylation of proteins 
Following pull down of CBD tagged fusions onto the Chitin column (see Section 
2.10.3), biotinylation of the protein was done by quickly flushing the column with 
buffer C3 and incubating the dry beads for 24 hrs at 4 °C. After the 24 hr incubation 
the protein was eluted in buffer G2. Following elution the proteins were either 
checked for the incorporation of the biotin tag using a western blot, or were used for 
spotting onto microarrays.  
 
2.14     Spotting biotinylated proteins onto avidin slides 
The slides were cleaned in piranha solution (H2SO4:H2O2, 7:3) for at least 2 hr. 
Following that slides were washed copiously with de-ionized water and rinsed with 
95% ethanol and dried. Then the slides were soaked in 1% solution of Silane (95% 
ethanol, 16 mM acetic acid) for 1 hr. The epoxy derivatized slides were then washed 
three times in 95 % ethanol and cured for 2 hrs at 150 °C. The slides were once again 
rinsed with ethanol and dried. Following this 40-60 µL of 1 mg/ml Avidin (SIGMA) 
in 10 mM sodium bicarbonate buffer was applied to the slides, covered with a cover 
slip, and incubated for 30 min. The slides were dried after washing with water. The 
unbound epoxides were reacted with 2 mM aspartic acid in 0.5 M sodium 
bicarbonate, pH 9, and covered with a coverslip. Following this the slides were 
washed with water and dried. The spotting was done manually, 2 µL spots of the 
samples were applied to the slides and allowed to react for 2-3 hrs in moisture 
chambers before drying them in air. The slides were then washed by incubating them 
in PBST (Tween 20, 0.1%) 10 times, 1 min each. Following this the antibody solution 
was applied to the slide (when required), was covered with a cover slip, allowed to 
incubate for 1 hr, before washing off the unbound antibody and dried in air.. The 
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slides were then scanned using the ArrayWoRx™ Microarray scanner (Applied 
Precision) at the respective wavelengths.  
 
2.15    Enzyme activity assays 
2.15.1 Testing activity of SrtA 
Fluorescence assay: SrtA/N-SrtA/N-SrtA-C184A/C-SrtA/C-SrtA-C184A, 20 µM, 
was incubated with EGFP-LPETG-V5, 20 µM and GG-TMR, 500 µM in reaction 
buffer R1 to a final volume of 100 µL at 37 °C for 1 hr. The reaction was stopped by 
adding buffer R2 to the reaction mix and boiling for 10 min at 95 °C. The reaction 
contents were then separated in a SDS-PAGE gel. Fluorescence of GG-TMR was 
scanned in gel using Typhoon 9200 (Amersham Biosciences), at the appropriate 
wavelength. 
 
Hydrolysis/transpeptidation activity: To test the hydrolysis activity, SrtA/C-SrtA/C-
SrtA-C184A, 5 µM, was incubated with ACC-LPETG-DABCYL, 100 µM in reaction 
buffer R1 to a final reaction volume of 100 µL (see Figure 4). The increase in 
fluorescence that would be observed due to hydrolysis (the fluorescent moiety and its 
quencher are separated) was followed using the Spectra Max Gemini XS (Molecular 
devices). For transpeptidation activity SrtA/C-srtA/C-SrtA-C184A, 5 µM, was 
incubated with ACC-LPETG-DABCYL, 100 µM and Gly6-His6, 100 µM in reaction 
buffer R1 in a final reaction volume of 100 µL (see Figure 4). The increase in 
fluorescence that would be observed due to transpeptidation (the fluorescent moiety 
and its quencher are separated) was followed using the SpectraMax GeminiXS 
(Molecular devices).   
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2.15.2   In vitro self-ligation assay 
To detect self labeling, N-SrtA/N-SrtA-C184A, was incubated with 500 µM, 
BIOTIN- LPETG, whereas as C-srtA/C-SrtA-C184A, was incubated with 500 µM 
G5-BIOTIN, in buffer R1 for 1 hr at 37 °C (see Figures 6 and 7). The reaction was 
stopped by adding buffer R2 to the reaction mix and boiled for 10 min at 95 °C. The 
reaction contents were then separated in a SDS-PAGE gel. Biotin was detected using 
anti-BIOTIN antibody; see Section 2.9 and expression table, Appendix B, for more 
details on the western blot.  
 
2.15.3   Self-ligation assay on the phage 
SrtA on phage was tested as follows, a 10 mL phage lysate was PEG precipitated (see 
Section 2.16.3) and re-suspended in 1 mL of buffer R1. 10 µL of this solution was 
used in a 50 µL reaction volume, using the same conditions as in Section 2.15.2 (see 
Figure 8).  Reaction aliquots were taken at required time intervals and the reaction 
stopped by the addition of buffer R2, followed by boiling at 95 °C for 10 min. 
Fluorescence tagging of the proteins was detected after running a SDS-PAGE and 










2.16  General phage methods 
 
2.16.1   Packaging of T7 phage DNA  
One tube of the T7 DNA packaging extract (Novagen) was thawed on ice and 
aliquoted into 4 tubes with 6.25 µL each. To this 1.25 µL of the ligation mix was 
added and stirred gently with a pipette tip. The reaction was allowed to proceed at RT 
for 2 hrs and was stopped by the addition of 75 µL of LB. The packaged phage was 
plated out (see Section 2.16.4) or stored up to 24 hrs at 4 °C. If long term storage is 
intended then phage was propagated and glycerol stocks were made.  
 
2.16.2  Amplification of phages  
M13 phages: The host cells (ER 2738, NEB) were grown to an OD600 of 0.095 at 37 
°C in LB broth supplemented with ampicillin at 100 µg/mL. The eluted phages were 
then added to the culture and allowed to grow until 4 hrs at 37 °C. The number of host 
cells was always in excess to the number of phages. All eluents were amplified in this 
manner. To amplify single plaques, plaques were picked into 1 mL OD600 = 0.095 
host cells and allowed to grow for 4 hrs at 37 °C. Following amplification the 
bacterial cells were pelleted at 10,000g for 10 min at 4 °C. The supernatant contained 
the phages. 
 
Rescue of phagemid: The XL1 blue cells containing the appropriate phagemid clones 
were grown at 30 °C in 2XYT broth supplemented with 2 % glucose (Glucose is 
added to the growth media to repress the protein expression from the Lac promoter of 
the phagemid prior to the addition of helper phages, overexpression of Gene III is 
toxic to the bacterial cells) and ampicillin, 100 µg/ml until a OD600 of 0.5. The cells 
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were then harvested and re-suspended in 2XYT broth (see Appendix A) containing 
ampicillin, 100 µg/ml, Kanamycin, 50 µg/ml, helper phages (M13-K07, NEB) at MOI 
0.1 and IPTG 0.4 mM. The incubation was continued at 37 °C for 1 hr without 
shaking, followed by incubation at 30 °C O/N at 250 rpm. Upon removal of cells the 
supernatant contained the phages. 
 
T7 phages:  The host cells (e.g., BLT5403, Novagen) were grown to an OD600 of 0.5 
– 0.8 at 37 °C in LB broth supplemented with ampicillin at 50 µg/mL. Phages were 
then added at a MOI of 0.001–0.01 (i.e., 100–1000 cells for each pfu) and allowed to 
grow until lysis was observed, typically 2 to 3 hrs at 37 °C. Following this the 
bacterial cell debris was pelleted at 10,000g for 10 min. The supernatant contained the 
phages. Amplification of single plaques was also done in a similar manner. 
 
2.16.3   PEG precipitation of phages. 
PEG precipitation of the phages was done by the addition 1/6th volume of buffer C   
(M13 phage) or 1/6th volume of buffer D (T7 phage) to the supernatant (see Section 
2.16.2), followed incubation on ice for a minimum of 1 hr up to O/N. Centrifugation 
was done at 10,000 g, for 15 min at 4 °C for 10 min to pellet the phages. The phages 
thus obtained were re-suspended in the desired buffer and desired volume.  
 
2.16.4   Storage, Serial dilution and titering of phages. 
Phage (M13/T7) is the most stable in LB and could be stored for several months in 
LB, at 4 °C, without any loss of titers. For long term storages however glycerol stocks 
were be made (15 % glycerol was added to the phage supernatant and frozen at -80 
°C). Serial dilution of phages was done in LB. Typically 100-fold dilutions, were 
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done in 96-well plates, using a 8-channel pipette, in a 96-well plate shaker, to shake in 
between dilutions. Up to 8 different samples were processed simultaneously, using 
just 8 tips (there was no need to change tips in between dilutions, just pipetting slowly 
was enough to prevent cross contamination). Titers from 96-well plates were counted 
on appropriate LB-Host-bacterial plates (The host bacteria (250 µL/90 mm dish), was 
grown to an OD600 ≥1, mixed with melted top agar (7 mL/90 mm dish) , at 55 °C,  
poured onto to LB/Antibiotic plates and allowed to solidify to make host bacterial 
plates; the procedure is the same for both M13 and T7 phages) using multi channel 
pipettes and spotting 2 µL volumes from each sample. Upon the appearance of 
plaques (8 hours, 37 °C for M13 phages, 3 hrs 37 °C for T7 phages) spotted areas 
containing discrete phages were counted and multiplied by the dilution factor to 
obtain the actual number of phages. All titers were done in triplicate and the average 
values were used. Typical phage titers for M13 phage after amplification was 1012 
pfu/mL , for T7 phage was 1010 pfu/mL , eluted titers varied between 0-105, serial 
dilutions were done accordingly.  
 
2.16.5    Plaque lift  
T7 plaques can be lifted onto nitrocellulose membrane and probed for protein 
expression using antibody. The plaques (500- 750 in number) were mixed with host 
bacteria (250 µl of OD600 ≥ 1 host bacteria /90 mm dish) and 7 mL of top agar/90 mm 
dish and plated out on LB/Amp plates. Once the plaques grow to 2-3 mm sizes the 
plates were chilled at 4 °C for a minimum of 1 hr. Nitrocellulose membrane cut to the 
size of the Petri-dish was marked on one side with a pencil, and laid on the agar plate 
gently. After a few min, the membrane was lifted out gently and allowed to dry for at 
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least 20 min. Following this the membrane was processed like a regular western blot 
membrane for any antibody.  
 
2.16.6  Sequencing phage  
 
2.16.6.1 M13 
The plaque whose DNA was to be sequenced was amplified in a small volume of 1 
mL. After amplification the cells were pelleted and 500 µL of the supernatant was 
removed into a fresh tube. Following this 200 µL of buffer C was added to the 
supernatant, mixed, and let to stand at RT for 10 min. The sample was then 
centrifuged at 10,000g for 10 min. The phages were pelleted at this step, and the 
supernatant was discarded. The pellet was re-suspended in 100 µL buffer E and 250 
µL ethanol, allowed to stand for 10 min. The DNA was recovered by spinning for 
another 10 min at 10,000g. The pellet was washed with 70 % ethanol, and air dried. 
The pellet was then re-suspended in 10 µL of TE buffer (10 mM Tris-HCL (pH 8.0), 
1 mM EDTA), and 5 µL was used for DNA sequencing (See section 2.6). 
 
2.16.6.2  T7  
Genes to be sequenced were amplified using the T7 up and T7 down primers (see 
Cloning table, Appendix B), purified using QIAGEN PCR purification kit, and used 
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2.17.7  Phage enrichment methods 
 
2.17.7.1   Affinity based enrichment of C-SrtA-T7 
Phages bearing the SrtA protein were diluted at 1 in 104 or 1 in 105 of bare T7 phages 
(wildtype T7). This pool of phages was then incubated with 25 µL of affinity beads 
(Ni-NTA beads were washed in buffer F and blocked for 1 hr at RT in blocking buffer 
H), in the binding buffer F and incubated for 1 hr at 4 °C in a rotating platform. 
Following incubation the unbound phages were washed away using 0.1% PBST, 1 
min each, 5 times. The bound phages were eluted by infecting the beads with 1 mL 
OD600 = 0.5 BLT5403 cells, and incubated until lysis occurred at 37 °C. The lysate 
was then centrifuged at 10,000g for 10 min to remove the bacterial debris. 100 µL of 
the supernatant was used directly for the next round of affinity enrichment. 2 µl of the 
phage supernatant was boiled in 100 µL of water for 10 min and 2 µL of this solution 
was used as template in a PCR reaction to detect enrichment using T7 Up and T7 
down primers. The selection was continued for 6 rounds.   
 
2.17.7.2  Activity based enrichment of C-SrtA-T7 
Activity based enrichment was carried out essentially in the same way as affinity 
based enrichment with the following modifications. Streptavidin beads 
(Promega)/Streptavidin microtiter plates (PIERCE) were washed with wash buffer G2 
and blocked with buffer H, incubated with 0.5 mM or with 10 µM of G5-BIOTIN 
respectively at RT for 30 min. The unbound G5-BIOTIN was removed by washing 
with 0.1% PBST at least 3 times. The phage bearing the C-SrtA was diluted at 1 in 
102 to 103 of bare T7 phages (wildtype T7), and incubated with the beads/plate in 
buffer R1 at 37 °C for 2 hrs. 13 rounds of enrichment were done. The following was 
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also tried, 0.5 mM of G5-BIOTIN was incubated with the diluted phages (see Section 
2.17.1.1) in buffer R1 for 2 hrs at 37 °C, the un reacted G5-BIOTIN was removed by 
PEG precipitation, and the phages were incubated with SA beads (washed with wash 
buffer G2 and blocked with buffer H) for 30 min at RT. The unbound phages were 
washed away and the bound were eluted as in Section 2.17.7.1.  
 
2.17.7.3 Biopanning against SA and 3CL mutant. 
Biopanning against the Streptavidin (SA) model protein and the 3CL mutant protease 
was done as follows. SA coated plates (High Binding capacity SA plates, PIERCE) 
was used for panning against SA, and 25 µL of GSH beads  was used to pan against 
the GST fusion protein, 3CL-C145A-GST (10 nM  concentration of the 3CL-C145A-
GST was used per assay ). The SA plates or the 3CL mutant bound beads (washed in 
PBS and blocked using block buffer H) were incubated with 2 x 1011 phage in 100 µL 
final volume of PBS for 1 hr at RT. Following incubation the unbound proteins were 
removed by washing 10 times, 1 min each with 100 µL of PBST (Tween 20, 0.1%). 
Elution of the bound phages was done using 100 µL of buffer G for 15 min at RT. 
This was neutralized immediately using 150 µL of 1M Tris, pH 9.1. A small amount 
of the eluent (10 µL) was used for titering and the rest was amplified as described 
above. The subsequent rounds were performed using 2 x 1011 phages from the 
amplified eluent. A total of 3 rounds were performed, at the end of which isolated 






2.17.7.4   Binding assay 
For each clone/target protein to be tested, 1 µg of the target protein was immobilized 
in separate wells of ELISA microtiter plate (NUNC). Immobilization of target was 
done by allowing the target to react with the ELISA plate in 100 µL of PBS buffer 
(see buffer G2, appendix A), pH 7.4, O/N at 4 °C. The unbound protein was washed 
off by rinsing the wells 3 times with PBST. The individual phage clones (109 pfu/each 
of cleared phage lysate) were added to the wells and allowed to react for 1-3 hrs at 
RT. The unbound phages were washed off using 5 washes, 1 min each with 100 µL of 
PBST (Tween 20, 0.1%). Elution of the phages was done using 150 µL of 200 mM 
glycine-HCL (pH 2), for 15 min at RT. The phages were then transferred to a new 
plate containing 150 µL of 1 M NaPO4 buffer (pH 7.5). The output was then titered, 










3. Results and Discussion  
 
 
In this thesis three different approaches to protein engineering and modulation have 
been evaluated. The first involves an intein mediated method to site specifically 
engineer proteins for immobilization onto the microarray. The second one is a 
selection scheme that should enable protein evolution of an enzyme SrtA has been 
designed and setup. As a third approach to protein modulation a phage display library 
of random peptides was used to identify binders for a viral protease. The identified 
binders may be used to design good inhibitors against the enzyme. The results and 
discussions from these three different projects will be presented separately in Sections 



















3A The intein mediated approach to site-specifically label proteins. 
An enzyme-mediated approach to modify proteins site-specifically is presented in this 
section. Two different approaches are described. The first one enables generation of 
N-terminal cysteine proteins, while the second allows biotinylation at C-terminus of 
proteins. 
 
3A.1   The intein based method to produce N-terminal cysteine proteins 
The Ssp Intein tag was used to generate N-terminal cysteine containing proteins for 
site-specific immobilization onto thioester functionalized glass slides by means of a 
highly specific chemical reaction known as native chemical ligation [109]. Terminal 
cysteine containing proteins were generated using the pTWIN vectors. These vectors 
allow the expression of target proteins with the self-cleavable modified Ssp DnaB 
Intein having a chitin binding domain fused at their N-termini. The recombinant 
protein was engineered by standard PCR-based methods and subsequently expressed 
to have a cysteine residue at its N-terminus by inducing intein splicing at pH 7. The 
N-terminal cysteine-containing protein thus produced was site-specifically 
immobilized onto thioester-functionalized slides via the chemoselective native 
chemical ligation reaction [6]. Only the terminal cysteine residue reacts with the 
thioester to form a stable peptide bond; other reactive side chains, including internal 







3A.1.1 Expression of N-terminal cysteine-containing proteins from bacteria.  
EGFP was cloned into the pTWIN vector to allow it to be expressed as a fusion to the 
Ssp DNAB intein at its N-terminus. An extra cysteine residue was introduced at the 
junction of EGFP and Intein. The construct thus obtained was sequence verified and 
transformed into ER2566 host cells for expression. In order to obtain a pure N-
terminal cysteine-containing protein, it was necessary that a sufficient amount of the 
uncleaved CBD-intein fusion protein was obtained before binding to a chitin column.  
By performing the protein expression at room temperature for 12 hrs, we were able to 
obtain a substantial amount of the fusion (at least 50 %; Lane 1 in Figure 13(a)) 
before chitin column purification.  In vitro cleavage of the fusion protein was further 
reduced by carrying out on-column loading and washings at 4 °C.  On-column 
cleavage and purification conditions were also optimized by carrying out the on-
column cleavage reaction at room temperature for 12 hrs using the cleavage buffer 
(pH 7.0) (see Section 2.11).  On average, highly purified N-terminal cysteine-
containing EGFP fractions could be routinely obtained with sufficient yield (~ 1.5 
mg/mL; Lanes 2-4 in Figure 13(a)), and directly used for spotting onto thioester slide.  
 
3A.1.2  Spotting N-terminal cysteine-containing EGFP onto thioester slides  
To confirm that the N-terminal cysteine-containing EGFP obtained this way is 
suitable for protein microarray generation, the concentration of the protein sample 
was adjusted to 1 mg/mL, and other series dilutions, before spotting onto a thioester-
functionalized glass slide.  Successful immobilization of EGFP was unambiguously 
confirmed by probing the slide with a Cy5-labeled anti-EGFP antibody (see Figure 
13(b)).  The spots arrayed on the glass slides were generally clear and defined and 
with relatively low background signals.  As observed from the native fluorescence of 
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the immobilized EGFP (Figure 13(c)), relative spot intensity reached saturation at 
about 0.2-1 mg/mL, indicated the upper limit of the amount of a protein that may be 
immobilized with this strategy.  Significantly, as little as 0.005-0.01 mg/mL of EGFP 
was sufficient to give an easily detectable signal. The observation of native EGFP 
fluorescence also served to confirm the proper folding of EGFP upon immobilization.  
 
3A.2  The intein mediated method to site-specifically label proteins derived from      
yeast 
The intein mediated strategy for C-terminal biotinylation of proteins and spotting onto 
to a microarray has been previously explored in our lab [7-11]. In this project the 
feasibility of producing proteins in yeast, biotinylating them at the C-terminus using 
the intein mediated method (see Figure 2) and immobilizing them onto microarrays in 
a high throughput fashion was evaluated.  Bacterial, mammalian and cell free systems 
have been previously used to express the target proteins prior to biotinylation either in 
vitro or in vivo [8-11]. Bacterial systems while providing good levels of expression, 
lack the complex environment present in the eukaryotic cell, e.g., they do not have 
post translational modifications of proteins. While it is feasible to express proteins in 
the mammalian system it is expensive and the yields are quite low. So the yeast was 
considered as an alternative. Yeast genetics is very well established, the yields of 
protein is acceptable and culturing yeasts is inexpensive. It was envisaged that if a 
high throughput system of expressing and biotinylating proteins from yeast could be 
setup, then the entire array of enzymes from yeast could be immobilized onto avidin 
surfaces and studied in a parallel fashion. While the 6000 yeast proteins have been 
immobilized in the microarray [110], functions of many ORF’s still remain to be 
discovered, an enzyme array typically consisting of all  known and putative enzyme  
 50
a) 
                         
     1      2      3    4     5      Lane No    










45     Fusion 
 








-100 100 300 500 700 900 1100
EGFP Conc.  ( mg/ mL)
                                                  
Figure 13: Results from N terminal immobilization strategy (a) Expression and 
purification of N-terminal cysteine-containing EGFP by in vitro intein-mediated 
cleavage on a chitin affinity column. Lane 1: Cell lysate containing overexpressed 
CBD-intein-EGFP fusion protein (~50 kDa).  Both the fusion and in vivo-cleaved 
EGFP (i.e. the 27 kDa band) were observed.  Lanes 2-4: The first 3 fractions eluted 
from chitin column.  Lane 5: Proteins retained in the chitin column after elution.  (b) 
Immobilization and detection of purified N-terminal cysteine-containing EGFP on a 
thioester slide.  Varied concentrations of EGFP (left to right in mg/mL: 1, 0.5, 0.2, 
0.1, 0.05, 0.02, 0.01, 0.005) were spotted, in triplicate, and probed with Cy5-labeled 
anti-EGFP antibody. The native fluorescence of immobilized EGFP was also 
measured and plotted graphically in (c).  
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ORF’s would facilitate such a process.  Also we sought to find out the most suitable 
intein (from the three commercially available inteins [31]) for use with the yeast 
system, because it is known that the expression and cleavage pattern of different 
intein fusion in different expression systems can be quite different [6-10]. 
Accordingly the C-terminal biotinylation system previously tested out in the bacterial 
and mammalian cells were extended onto yeast.  
 
3A.2.1 Expression levels and the in vivo cleavage pattern of the Intein-fusion 
proteins in yeast 
The genes EGFP-Intein 1 (Intein1: Mxe GYR Intein from pTWIN1 vector, NEB), 
EGFP-Intein 2 (Intein 2: Mth RIR Intein from pTWIN2 vector, NEB), and EGFP-
Intein 3 (Intein 3: Sce VMA Intein from pTYB1 vector, NEB) were cloned into the 
gateway system vector pYES-DEST52, using the gateway methodology (see Figures 
9 and 10).  The pYES-DEST52 vector is meant for expression of proteins from yeasts, 
the cloned gene is placed under the “GAL” promoter inducible by the addition of 
galactose to the medium. After DNA sequence verification of the genes the plasmids 
containing the genes were transformed into yeast INvSC1 strain. The expression 
levels of the proteins from the yeast host were monitored by scanning for the native 
fluorescence of EGFP in different time intervals (see Figure 14). As evident from 
Figure 14, the best expression levels were obtained from constructs that had the 
Intein-3 fused to the EGFP, followed by that obtained from Intein 1. Intein 3 has its 
origin from the yeast Saccharomyces cerevisiae, while Inteins 1 and 2 were from 












Figure 14: Native fluorescence of EGFP-Intein fusion from yeast after cell lysis and 
clarification. 1, 4: EGFP-Intein1 fluorescence after 0 and 24 hrs post induction. 2, 5: 
EGFP-Intein 2 fluorescence after 0 and 24 hrs post induction. 3, 6: EGFP-Intein 1 
fluorescence after 0 and 24 hrs post induction. Fluorescence was detected by scanning 
through using the Typhoon 9200 scanner at Excitation λ: 488nM  
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Figure 15: Expression time line of the three EGFP-Intein-CBD fusions in the yeast 
host detected using anti-CBD western blot.1: EGFP-Intein2-CBD, after 24 hrs of 
expression. 2: EGFP-Intein1-CBD, after 24 hrs of expression. 3: EGFP-Intein3-CBD, 
after 10 hrs of expression. 4: EGFP-Intein2-CBD, after 10 hrs of expression. 5: 
EGFP-Intein1-CBD, after 10 hrs of expression. 6: EGFP-Intein3, after 4 hrs of 
expression. 7: EGFP-Intein2, after 4 hrs of expression. 8: EGFP-Intein1, after 4 hrs of 
expression. 8: EGFP-Intein3, after 24 hrs of expression. Red arrows indicate 










blot with anti-EGFP antibody corroborated the fluorescence pattern observed with the 
protein expression pattern observed on gel (see Figure 15). Also for the success of the 
C-terminal Biotinylation strategy it is important that the fusion is obtained intact so 
that it can be pulled down using the chitin beads and will be available for 
biotinylation. From the western blot results (see Figure 16) it was evident that at least 
30% of the fusion was cleaved off inside yeast for the constructs with Intein 1 and 3 
and almost no fusion was detected in the case of the Intein 2. But however since 
substantial fusion ~ 70% still remained in the cell for Intein 1 and 3 fusions, and 
because of the higher levels of expression from the Inteins 1 and 3, it was decided to 
use only Intein 1 and 3 fusion proteins for all further experiments.  
 
3A.2.2 On-column cleavage and generation of biotinylated protein 
The fusion protein Intein 1/3 -EGFP was purified on chitin beads from a 5 mL yeast 
culture, and run on a SDS-PAGE gel. It was found that the levels of expression, and 
yields after purification were such that only faint bands were visible after the 
coomasie staining of the gel (see Figure 17). Nevertheless due to the very small 
amounts of proteins that is required for spotting onto a microarray (fg/spot, [110]) it 
was decided to proceed further and biotinylate the proteins using cysteine-biotin. 
Upon incubation of the fusion protein with MESNA (a thiol reagent that induces 
cleavage of the engineered intein from the fusion) and cysteine–biotin the splicing 
process of the engineered intein was initiated and a thioester group was generated at 
the C-terminus of the EGFP. This group was then attacked by the SH group of the 
cysteine from cysteine – biotin to yield a native peptide bond with biotin on the C-
terminus (see Figure 2). Upon cleavage and elution using MESNA and Cys-biotin,  
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Figure 16: In vivo cleavage pattern of the three EGFP-Intein fusions in yeast crude 
cell lysate as detected using anti-CBD western blot.1: EGFP-Intein1-CBD, 2: EGFP-
Intein 3-CBD, 3: EGFP-intein2-CBD. 
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Figure 17: Purification of EGFP-Intein 3 from yeast small scale cultures. Lane 1: 20 
µL of EGFP-Intein-3 bound to chitin beads boiled with buffer R2 (without DTT). 
Lane 2: Blank. Lane3: 20 µL of EGFP-Intein-3 bound to chitin beads boiled with 
buffer R2 (with DTT). Note: DTT induces cleavage of intein from the fusion. 
 
 




Figure 18: Effect of different concentrations of Cys-Biotin on the biotinylation 
efficiency of EGFP produced in different hosts. 1, 2: EGFP-biotin cleaved off from 
EGFP-Intien-1, using 10mM and 5mM Cys-Biotin respectively. 3, 4: EGFP-biotin 
cleaved off from EGFP-Intien-3, using 10mM and 5mM Cys-Biotin respectively. 5, 6: 
EGFP-biotin cleaved off from EGFP-Intien-1, using 10mM and 5mM Cys-Biotin 
respectively. 1-4: Yeast host, 5, 6: Bacterial host. Biotinylation was detected using 
anti-biotin western blot 
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a western blot (see Figure 18) using anti-biotin antibody revealed a band  
corresponding to the biotinylated EGFP. The effect of the concentration of cysteine-
biotin on the biotinylation efficiency was evaluated, 10 mM cysteine-biotin gave the 
best levels of biotinylation. Also Intein-3 fusions gave higher yields than Intein-1 
fusions (see Figure18). Hence it was decided to choose Intein-3 as the final intein of 
choice for all further experiments.  
 
 
3A.2.3 Detection on the microarray 
Following biotinylation the proteins that were eluted, were napped to remove the 
excess cysteine–biotin. Then the proteins were spotted manually onto avidin 
functionalized glass slides, with FITC-biotin as control and probed with anti–EGFP-
FITC. Upon incubation, washing and scanning for fluorescence using the array 
scanner the FITC-Biotin controls retained their fluorescence, while no significant 
fluorescence was found either from native the fluorescence of EGFP or from the anti 
–EGFP-FITC spots. The levels of protein obtained from a small scale culture of yeast 
was thus was not high enough to obtain immobilization onto the array. Indeed when 
biotinylated proteins from bacteria were used for immobilization we were able to see 
significant native EGFP fluorescence on the slides. Moreover biotinylation efficiency 
though quite high ~ 70%, considering the levels of protein obtained in the first place 
may not have been sufficient enough to allow immobilization onto the microarray.  
Although this was not a problem as it only requires protein purification from large 
scale cultures, it was realized that purification of hundreds of proteins from yeast in a 
large scale fashion was tedious and not practical. Hence it was concluded that despite 
the low levels of proteins needed for microarray immobilization, the expression level 
of proteins in yeast and the efficiency of the subsequent steps of biotinylation were 
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3B Designing a selection scheme to evolve SrtA on phage 
SrtA, a transpeptidase isolated from the Staphylococcus aureus bacterium, has proven 
useful in protein ligation and purification applications [13, 101]. Here in this project it 
was hypothesized that SrtA could be used to ligate fluorescent probes to proteins 
engineered to have the LPETG motif and ultimately be useful for imaging proteins in 
live cells. SrtA is very robust in living cells [88], but in vitro the performance of SrtA 
is compensated. Several reasons have been proposed for this. In vitro analysis 
indicated that a weak km of 5.5 mM was observed for the LPETG substrate, a km of 
140 µM was observed for the penta-glycine substrate and a kcat of 0.27/sec was 
observed for the enzyme [99]. The wild type SrtA and its two natural substrates are 
membrane anchored. The SrtA DNA sequence that was cloned lacks the membrane 
anchor to make it soluble. The crystal and solution structures of Sortase were obtained 
without the membrane anchor and hence the importance of the truncated 59 amino 
acids is unknown. Calcium binding stimulates SrtA; hence it has been proposed that 
the full length SrtA might form specific interactions with the membrane 
phospholipids that would contribute to its activity in vivo [99]. 
 
3B.1 The N-terminus extension scheme 
To improve the activity of SrtA in vitro it was decided to evolve SrtA using protein 
evolution techniques. Protein evolution of an enzyme as described before requires a 
selection scheme that will allow the isolation of the desired enzymes from a pool of 
random mutants. In this project a selection scheme for the evolution of SrtA was 
designed and successfully set up. Using this selection scheme and a whole library of 
random mutants of SrtA, it may be possible to evolve more active members of the 
SrtA enzyme. The selection scheme (see Figure 5) is similar to the product capture 
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approach to evolve enzymes [81, 82].  Two different selection schemes were set up. 
One, the N-terminal extension scheme, displays a N-SrtA (N-terminus extended with 
(GGGSE)3 amino acid sequence) on the phage M13. SrtA was fused to one of its 
substrates 2HN-GGG on its N-terminal side (see Figure 7). It was hypothesized that if 
the N-terminus is extended enough it should bring the substrate of SrtA into its own 
active site. The distance between the active site cysteine 184 and the N-terminus was 
estimated to be around 26.79 °A. It was estimated that 8-10 amino acids residues 
should be enough to extend the N-terminus of SrtA to its active site (note that SrtA 
was cloned in without the original N-terminal 59 amino acid residues to keep it 
soluble). Accordingly a 15 amino acid peptide sequence GGGSEGGGSEGGGSE was 
fused to the N-terminus of SrtA. The “SE” repeat was known to confer flexibility to 
peptides and is generally used as linker sequence [112].  It was foreseen that the N-
terminal extended SrtA both on the phage and in solution, would react with Biotin –
LPETG-COOH and thus label itself (see Figure 7). Thus if a pool of active and 
inactive members of SrtA was displayed on the phage each with their N-termini 
modified, only the active ones will react to label themselves, and they can be isolated 
using avidin beads, amplified and enriched.  
 
The M13 phage display has some inherent disadvantages [113]. The protein to be 
displayed has to be secreted out into the periplasmic space of the bacterial cell wall. 
Not all proteins retain activity after being secreted into the periplasm and some resist 
transport. To circumvent this shortcoming, other bacteriophages like the T7 phage 
have been used to display proteins [114]. Proteins displayed on the T7 phage need not 
be secreted as T7 phage is a lytic phage, moreover proteins can be displayed as C -
terminal fusion to the phage capsid protein 10B. Thus considering the fact that SrtA 
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might resist export or might not be active after export into the periplasmic space when 
packaged into the M13 phage, we decided to display SrtA on the T7 lytic phage. Also 
whether N- or C-terminal ligations would work was unknown at that time.  
 
3B.2 The C-terminus extension scheme 
The C-terminal selection scheme is similar to the N-terminal scheme.  It displays a C-
SrtA (C-terminus extended with LPETG) on the T7 phage. SrtA was fused to its 
substrate LPETG on its C-terminal side (see Figure 6). It has been previously shown 
that SrtA fused to the LPETG substrate on its own C-terminus, can catalyze the 
transfer of a Gn peptide onto itself [101]. Based on this report, it was decided to fuse 
LPETG to the C-terminus of SrtA and display it on the T7 phage. It was foreseen that 
the C-terminal extended SrtA both on the phage and in solution, would react with G5-
Biotin and thus label itself (see Figures 6 and 8). Thus from a pool of active and 
inactive members of SrtA displayed on the phage each with their C-termini modified, 
only the active ones will react to label themselves, and they can be isolated using 
avidin beads, amplified and enriched.  
 
3B.3 Activity of SrtA with N- and C-terminal extensions   
As a proof of the concept to the selection scheme, it was decided to prove that N-SrtA 
and C-SrtA would carry out the self-ligation in solution, i.e., not bound to the surface 
of the phage. Accordingly, N-SrtA/N-SrtA-C184A with N-terminal sequence 
extension (GGGSE)3, and the C-SrtA/C-SrtA-C184A with C-terminus extension 
(GGLPETG) were constructed by adding on the required sequences onto the primers,  
cloned into vectors pFAB5c.HIS-Exp and pDEST17 vectors respectively. Both N and 
C-SrtA have a C-terminal HIS tag, by virtue of which they were purified (see Figure 
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19). In addition the N-SrtA has a pelB sequence that allows it to be exported to the 
periplasm of the bacteria, once exported the export sequence is cleaved off. C-SrtA 
and N-SrtA expressed as well as the wild type SrtA (was cloned into pDEST17 by a 
colleague in the lab). SrtA and C-SrtA migrate just above the 24 kDa band of the 
protein ladder (see Figure 19) in a SDS-PAGE gel. However two very close bands 
were observed for the N-SrtA, both equal in intensity, one of them the periplasmic 
protein (with the pelB sequence cleaved off) and the other the cytoplasmic full length 
protein. The pelB sequence is about 22 aa long, ~ 2.2 kDa and is clipped off by the 
residential proteases once transported into the periplasm. The proteins N/C-SrtA were 
purified in good yields using the Ni-NTA-column. To determine if N- and C-terminal 
extensions perturb the function of SrtA, N/C-SrtA were incubated with EGFP-LPETG 
and GG-TMR , native SrtA catalyses the transfer of Gn , n = 1 to 5 ,  to the LPETG 
motifs of proteins by cleaving in between the T-G of LPETG and ligating the Gn  
peptide to threonine. The activity assay was carried out with appropriate positive and 
negative controls (see Figure 20), and it was found that the activity of N/C-SrtA was 
comparable to the wildtype the active site mutants were not active as expected, in that 
they were unable to transfer GG-TMR onto EGFP-LPETG even after 12 hrs of 
incubation at 37 °C. Also the hydrolysis and transpeptidation activities of C-SrtA 
were measured independently using quenched fluorescent probes (see Figures 21 and 
22). As judged from the RFU, activity of C-SrtA was a bit lower than that of SrtA, but 
this could also be due to the minor differences in concentration of the two proteins 





3B.4 Self-ligation assay of N/C-SrtA  
In order to test the concept that SrtA with an N-terminal GGGSE extension can 
transfer a LPETG peptide onto its own N-terminal GGG- extension and that C-SrtA 
can catalyze the transfer of GG peptide onto its own C-terminus, the enzymes were 
incubated with their respective substrates bound on SA beads. In the case of N-SrtA it 
was LPETG-Biotin and in the case of C-SrtA it was G5-BIOTIN. After the reaction 
the beads were boiled in buffer R2 and run on a SDS PAGE gel. Upon probing with 
anti-biotin antibody it was evident that N/C-SrtA could catalyze the transfer of their 
substrates onto themselves, while the active site mutants lacked the activity (see 
Figure 23). As expected a single band was observed in the case of N-SrtA. As noted 
previously during the purification of N-SrtA two closely spaced bands were observed 
in the SDS-GEL. The bigger of them, SrtA with the pelB sequence does not contain 
an N-terminal glycine and the N- terminus would be too far away from the active site 
for any catalysis. This proved that the concept of capturing active enzymes using their 
substrates as tags could be extended to the phage system.  
 
3B.5 Display of N/C-SrtA on phages   
N-SrtA/C-SrtA genes were cloned into vectors that will enable their expression on the 
phage. Cloning of N-SrtA followed regular cloning procedures and it was cloned in to 
pFAB5c.HIS phagemid, while C-SrtA had to be cloned into the T7 genome (see 
Figure 11) 10-3-B. Recombinants were identified using a PCR screen, sent in for 
DNA sequencing and verified. While the production of T7 phages is straightforward, 
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Figure 19: Purification of SrtA and the different versions of SrtA. SrtA and the N- and 
C-terminal extensions of SrtA (C-SrtA and N-SrtA), purified via Ni-NTA column, run 
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Figure 20: Activity assay of SrtA, N-SrtA and C-SrtA as detected by in gel 
fluorescence scanning. 1: N-SrtA, EGFP-LPETG and GG-TMR. 2: N-SrtA-C184A, 
EGFP-LPETG and GG-TMR. 3: C-SrtA, EGFP–LPETG and GG-TMR. 4: C-SrtA-
C184A, EGFP–LPETG and GG-TMR. Fluorescence visualized by running the 













to package pFAB5c.HIS-N-SrtA into phages, the host cells carrying the phagemid is 
infected with helper phages. The phagemid is packaged into helper phage coat 
proteins preferentially over the helper phage genome. Large scale cultures of SrtA-
M13 phage and SrtA-T7 phage were produced and PEG precipitated. It was not 
possible to detect the expression of N-SrtA as the cloning scheme did not facilitate the 
addition of any affinity tag (it was required to keep the N-terminus free). But it was 
possible to introduce a C-terminal affinity tag into C-SrtA, accordingly a HIS tag was 
introduced. Expression of SrtA on the T7 phage was verified using a plaque lift 
method and regular western blotting procedures (see Figures 24 and 25).  
 
3B.6 Activity assay of SrtA on phage 
It is well known that many enzymes when displayed onto the surface of phages do not 
retain their activity or the activity drops down to some extent [3]. For the selection 
scheme to work however it is imperative that the SrtA displayed on phage retains its 
activity to an extent that is detectable. N/C-SrtA on phage should be able to catalyze 
the same functions like N/C-SrtA in solution. PEG precipitated C-SrtA-T7, N-SrtA-
M13 phages were incubated with EGFP-LPETG-V5 and GG-TMR, and analyzed for 
fluorescence by separating the components in a SDS gel and scanning using the 
typhoon scanner. A faint but definite fluorescence band corresponding to the size of 
the 10B-SrtA-LPETG-G-TMR fusion and EGFP-LPETG-G-TMR was observed (see 
Figures 25-27), which was absent in SrtAC184A, displayed on the T7 phage. No band 
corresponding to the EGFP-LPETG-G-TMR was observed when EGFP-LPETG and 















                  
Figure 21: Transpeptidation of SrtA and C-SrtA as measured using quenched 
fluorescent substrates. SrtA (A1), C-SrtA (B1), C-SrtA-C184A (C1), or no enzyme 
(D1) was incubated with quenched fluorescent substrate (ACC-LPETG-DABCYL) 
and GG-peptide to measure the transpeptidation activity of SrtA. When kinetics was 
followed through the ACC channel in a microplate fluorescence reader, definitive 
increase in fluorescence was observed in the case of A1 and B1, whereas fluorescence 
of C1 and D1 remained in the background levels.  
 














Figure 22: Hydrolysis activity of SrtA and C-SrtA as measured using quenched 
fluorescent substrates. SrtA (A1), C-SrtA (B1), C-SrtA-C184A (C1), or no enzyme 
(D1) was incubated with quenched fluorescent substrate (ACC-LPETG-DABCYL) to 
measure the hydrolysis activity of SrtA. When kinetics was followed through the 
ACC channel in a microplate fluorescence reader, definitive increase in fluorescence 
was observed in the case of A1 and B1, whereas fluorescence of C1 and D1 remained 
in the background levels. 
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Figure 23: Self ligation assay of N-SrtA and C-SrtA as detected by anti-biotin western 
blot. 1: C-SrtA with G -biotin on SA-beads. 2: C-SrtA-C184A with G5 5-biotin on SA-
beads. 3: N-SrtA with Biotin-LPETG on SA-beads. 4: N-SrtA-C184A with Biotin-
LPETG on SA-beads. Biotin was detected using anti-biotin western blot. Red arrow: 
A higher molecular weight band was always seen with C-SrtA both during 
purification and activity assay, which was absent from C-SrtA-C184A. Molecular 
weight indicates that it could be a dimer. (For concentrations of each component in 
the assays, please refer to materials and methods) 
 
                                      
 
Figure 24: Plaque lift: C-SrtA-T7-Phages were lifted onto nitrocellulose membrane 
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Figure 25: Expression levels and activity assay of C-SrtA on the T7 phage as detected 
by anti-biotin western blot. 1: C-SrtA-10B-fusion, 2: C-SrtA-C184A-10B-fusion, 3: 
C-SrtA-C184A-10B-fusion incubated with GG-TMR, 4: bare T7 phages incubated 
with GG-TMR, 5: C-SrtA-10B-fusion incubated with GG-TMR. Red arrow: upon 
ligation with GG-TMR, the 6X-HIS tag is lost from the C-SrtA-10B-fusion.  
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 3B.7 Enrichment of SrtA-phages from a pool of bare phages 
While whether or not N-SrtA on M13 was active remained a question, it was decided 
to do further experiments with the C-SrtA. The T7 SrtA phages were diluted into bare 
T7 phages (T7 wildtype phages). The HIS tag on SrtA, as well as activity of SrtA was 
used to enrich the SrtA phages from the wildtype T7 phages.  
 
3B.7.1  Affinity based enrichment  
The SrtA phages on T7 were diluted at 1 in 104 or 1 in 105, into non-SrtA wildtype 
phages. This mixture was applied to the Ni-NTA beads (washed and blocked with 
BSA), and incubated at 4 °C for 1 hr. After removal of the unbound phages, the 
phages were subjected to amplification. This was continued until 6 rounds. After 
every round a PCR (using primers that amplified out the SrtA gene specifically) was 
done using the amplified pool of phages as template. After 3 rounds, enrichment was 
evident and became complete in six rounds (see Figure 28).  
 
3B.7.2  Activity based enrichment  
 The SrtA phages on T7 phages were diluted at 1 in 102 or 103, in non-SrtA phages. 
This mixture was applied to the G5-Biotin bound SA beads, and incubated at 37 °C for 
2 hrs. After removal of the unbound phages, the phages were subjected to 
amplification. This was continued until 6 rounds. After every round a PCR using 
primers that amplified out only the SrtA gene was done using the amplified pool of 
phages as template. Unlike the affinity based enrichment, activity based enrichment 
how ever did not occur even at the end of 6 rounds, extending the number of rounds to 
13 had no effect either. Other experimental conditions were tried but without any 
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effect (see Figure 29). As can be seen from Figure 29b, no specific enrichment was 
detected in any of the conditions tried. When non stringent wash conditions were 
used, a faint band corresponding to the size of the SrtA gene was found in all samples 
(see Figure 29b), despite the absence of the G5-Biotin peptide in the negative control 
samples. The reason why we failed to achieve activity based enrichment may be that, 
the activity of SrtA on phage was too low to begin with to allow any significant 
binding during the 1st round of enrichment. Moreover high background levels of 
binding of phage to SA beads might have made it impossible to detect any low 























Figure 26: Activity assay of C-SrtA on T7 phage: 1: C-SrtA-T7phage, GG-TMR and 
EGFP-LEPTG-6XHIS. Red arrow indicates EGFP-LPETG-GG-TMR (For 
concentrations of each component in the assays, please refer to materials and 
methods). 
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Figure 27: Self ligation assay of C-SrtA on T7 phage: 1: T7phage, GG-TMR, 2: C-
SrtA-C184A-T7phage, GG-TMR, 3 to 7: decreasing concentrations of GG-TMR 
incubated with C-SrtA-T7phage. 
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Figure 28: Affinity enrichment of C-SrtA-T7-phage. M: 1 kB DNA ladder, NEB. 1 to 
6: rounds 1 to 6 of affinity enrichment (1 in 104, i.e., 1 C-SrtA-T7-phage in 104 bare 
T7 phages).  1 to 6: rounds 1 to 6 of affinity enrichment (1 in 105, i.e., 1 C-SrtA-T7-
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Figure 29a: Activity based enrichment of C-SrtA-T7. Odd lanes, C-SrtA-T7:T7, 
1:100, with G5-Biotin. Even lanes: C-SrtA-T7:T7, 1:100, without G5-Biotin. Lanes 1 
to 8 represent 4 rounds of enrichment. Lane a: C-SrtA-T7:T7, 1:100, with G5-Biotin 
in round 0 of enrichment. Lane b: C-SrtA-T7:T7, 1:100, without G5-Biotin in round 0 
of enrichment. Lane M: 1Kb ladder from NEB. Experiment was done using less 
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Figure 29b: Activity based enrichment of C-SrtA-T7. Odd lanes, C-SrtA-T7:T7, 
1:100, with G5-biotin. Even lanes: C-SrtA-T7:T7, 1:100, without G5-Biotin. Lanes 1 
to 8 represent 4 rounds of enrichment. Input material to the experiment was the same 
as used in Figure 29a. Lane M: 1Kb ladder from NEB. Experiment was done using 





3C Detection of binders of 3CL protease from a phage library  
The 3CL protease was an important drug target for the Severe Acute respiratory 
Syndrome which had its origins in China and spread to other parts of the world. 
Several groups have been engaged in the discovery of inhibitors for the viral protease 
yet no significant progress has been made. In this project, determining inhibitors of 
the protease using the phage display approach was considered. While the traditional 
method of identifying peptide inhibitors was through the construction of a large 
peptide libraries and scanning for inhibition using a suitable assay, as a quicker 
alternative it was decided to scan a commercially available random peptide phage 
display library for good binders to the active site mutant of the viral protease. 
Incubating the library with the active enzyme will cleave most of the binders, but 
incubation with the active site mutant will enable isolation of binders. Upon 
emergence of a strong binder a group of similar peptides maybe then be designed, 
synthesized and the inhibition of the protease can be studied in solution. 
 
3C.1 Biopanning of a model protein Streptavidin  
A random 7 mer peptide library on the surface of the filamentous phage was 
purchased from NEB. The library contains peptides displayed as N-terminal fusions to 
the capsid protein gene III of the M13 phage. Also the M13 phage coded for the 
enzyme β-Galactosidase and hence the library phages appear blue upon X-Gal 
selection. Because of the troublesome contamination of the library phages with 
environmental M13 phages, this blue/transparent selection served useful to identify 
library phages from contaminating environmental phages at all times. In order to 
optimize the biopanning assay conditions, at first a biopanning experiment with the 
protein Streptavidin was undertaken. In searching for peptide binders to SA from a 
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random peptide library on the microarray, some groups have reported a strong binding 
preference to the peptide sequence “HPQ” [111].  The phage library contained 2 x 109 
electroporated clones, amplified once to give a total of 70 copies of each sequence as 
opposed to the total possible 20 x 107 =1.28 x 109 sequences. 96-well SA high binding 
capacity plates from PIERCE were found to be convenient for all the procedures of 
biopanning. As a negative control to the experiment, the library was also panned 
against BSA coated in polystyrene wells. Every round was characterized by 3 steps, 
incubation of a definitive number of phages (1 x 1011 phages which represent 100 
copies of every sequence in the library) with the SA plates; washing to remove the 
unbound phages; elution of bound phages done using glycine-HCL, pH 2.2, and 
neutralization of the pH with Tris-buffer (see Figure 3). After the elution the phages 
were amplified for the next round of selection. After every round of selection the 
input and the output titers were counted. As compared to the negative control the 
titers from the SA plates were a 100 fold higher. This was consistently observed in all 
the three rounds, while the titers from the BSA plates were roughly the same in all the 
three rounds. After three rounds individual plaques were picked and surveyed for 
binding to SA using the binding assay.  
 
3C.2 Binding assay to detect the strongest of binders 
After three rounds of selection individual plaques were picked and inoculated to 
amplify them separately. 24 individual clones thus obtained were incubated in SA 
microtiter plates, 1 x 109 of each per well. After incubation for an hour at RT, the 
wells were washed to remove unbound phages and the bound phages were eluted as 
described in Section 3C.1 and titered. The percentage of input phages recovered was 
calculated. Amongst the different clones 16 representative clones were sequenced. 
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Clone No Input Output 
% Input 
recovered 
No of residues 
conserved 
Sa_1 6 x 1010 1.4 x 107 0.02 3 
Sa_2 4 x 1010 9.1 x 107 0.214 1 
Sa_3 4 x 1010 ND -- 7 
Sa_4 1 x 1010 7 x 106 0.006 3 
Sa_5 ND 2.5 x 106 -- 1 
Sa_6 4 x 1010 1.75 x 106 0.001 3 
Sa_7 ND 1 x 107 -- 0 
Sa_8 7 x 1010 5.25 x 106 0.007 2 
Sa_9 2 x 1010 2.88 x 106 0.01 0 
Sa_10 2 x 1011 1.66 x 106 0.0008 2 
Sa_11 ND 1.05 x 106 -- 3 
Sa_12 ND 1.4 x 108 -- 0 
Sa_13 4 x 1010 5.25 x 105 0.0001 0 
Sa_14 1 x 1010 1.4 x 108 1.4 7 
Sa_15 1 x 1010 7 x 105 0.007 2 
Sa_16 0.5 x 1010 1.2 x 108 2.4 7 
 







They contained both strong binders (> 0.1% input pfu recovered) and weaker binders 
(> 0.1% input pfu recovered) (see Table 1). The sequencing results revealed the 
presence of the strongly conserved motif “HPQ“ in some of them (see Table 3). In an 
independent experiment which was done using far more stringent washes (0.5% 
Tween 20), most of the 8 clones sequenced were found to contain the “HPQ” 
consensus (see Table 2). Thus the power of the phage display approach was 
demonstrated in that, it was possible to fetch out a single peptide sequence from a 
billion. Also the protocols for biopanning were thus optimized.  
 
3C.3 Expression and Mutation of the 3CL protease  
The clone bearing the 3CL protease, pGEX-4T1-3CL was kindly given to us by Prof. 
Song Jian Xing of DBS, NUS. The vector allows fusion of cloned genes to GST 
protein, thus facilitating affinity purification using GSH columns. Using the method 
of full length plasmid amplification from STRATAGENE, to produce site directed 
mutations, the active site Cysteine 145 of the protease was mutated to Alanine (see 
Figure 12).  The clone, pGEX-4T1-3CL-C145A, thus obtained was sequence verified 
and transformed into BL-21-DE3 cells. Upon induction of expression with IPTG, the 
protein was purified using GSH beads, run on the SDS-PAGE and was found to be  
> 95% pure (see Figure 30).  
 
3C.4 Bio-panning against the 3CL protease mutant  
Having stabilized the conditions for biopanning, 3CL mutant was immobilized onto 
GSH beads (by means of its GST tag). Using the same library and similar panning 
conditions as in Section 3C.1, 3 rounds of the selection were carried out. The titers 
were obtained at the end of each round was compared with the negative controls (the 
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Figure 30:  Expression levels of 3CL protease and 3CL protease mutant. 1: Crude cell 
lysate from un-induced lane, 2: Crude cell lysate of over expressed 3CL protease. 3: 




Clone number Sequence 
1 S  L  I   A  H  P Q 
2 T  L  L  A  H  P Q 
3 H  F W  D  H  P Q 
4 S  L  I   N  H  P Q 
5 H  F W  D  H  P Q 
6       T  L  L  A  H  P Q 
7 L  L  W  P  S  L  P 
8 S T  G   S  T  F W 
 
Table 2: Sequencing results of the peptides from biopanning against Streptavidin. 6 
clones out of the 8 that were sequenced contained the strongly conserved motif HPQ, 
the rest showed conserved residues in various positions as indicated above in red 






Clone  No Sequence 
Sa_1 S    W     L    S    W      P     R 
Sa_2 A    M     L    F     E     W    S 
Sa_3 N    L     V    N     H     P    Q 
Sa_4 N    L     Q    F     M     P    Y 
Sa_5 H     P     G    N    S      Y    N 
Sa_6 T     E      L    Q    S      P    D 
Sa_7 L     G     C    A    C     C    S 
Sa_8 T     T      I     S     P     H    V 
Sa_9 D     F     S    W    V     S    H 
Sa_10 S     T     T    A    Y     W     A 
Sa_11 S      P    V    A     P     W     P 
Sa_12 H     T     S    S     P      T     F 
Sa_13 Sequencing results not good 
Sa_14 N     L     I     N    H      P     Q 
Sa_15 X    L      P    H    T      F     Q 
Sa_16 S     L      I      A    H     P     Q 
 
 
Table 3: Sequencing results of the peptides from the binding assay, biopanning 
against SA. 3 clones out of the 16 that were sequenced contained the strongly 
conserved motif HPQ, the rest showed conserved residues in various positions as 





phage library applied to the GSH beads). However no clear increase in titers as seen 
for the SA control experiment was visible. If the binders to the 3CL mutant were 
weak in binding affinity then no clear difference in titers between that of the protease 
and BSA bound beads could be expected. Hence more rounds of selection were 
carried out. At the end of 6 rounds, 24 clones were selected for binding assay against 
the 3CL mutant immobilized on ELISA plates. However upon counting the titers, 
many of the clones were found to have negligible binding, almost equivalent to that of 
the negative control (BSA immobilized on the ELISA plates). Nevertheless some of 
the binders were sequenced. None of the sequences obtained were similar to the 
substrates already known (see Table 4), and in corroboration to the binding assay 
results, no consensus sequence had been reached. The reason why we failed to isolate 
good and specific binders could be manifold. It was expected that atleast “substrate 
like” sequences would be isolated. Studies have established that the 3CL protease 
prefers a hydrophobic residue in the P2 position, a glutamine in the P1 position, and  
alanine, serine or glycine  residue in the P1’ residue [106]. The probability of finding 
the reported substrate sequence “AVLQSGF” was calculated as per the suggestions 
given in the manual of the peptide phage display library. The formula suggests the 
existence of at least 3 such sequences in the library. During the course of the 
experiments, the library material obtained from the manufacturer was amplified once 
to give more material. However, once the library is replicated to produce more 
material the chances of finding all the sequences from the initial library are reduced. It 
largely depends on whether all the phages in the original library infected and 
replicated in the host cells. Also it might be possible that the library that was used 
contained no good binders at all. Many groups in fact custom-make dedicated peptide 
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libraries that includes the known binding preferences of the protease they study [69-
75].   
 
 
Clone number Sequence 
1 H  Q  P  S  R  Q  Y 
 
2 L  A  H  S  R D  P 
 
3 I  W  A  F  A  T   P 
 
4 S   P   P   P  P  S  M 
 
5 A  R  V  T  E  M  S 
 
6 Q  H  M  T  Q  V  T 
 
7 Y  P  Y  Q  W  P  K 
 
8 L  P  T  L  D  R  G 
 
9 E  S  A  P  T  S  T 
 
       












4. Conclusions  
 
In this thesis three different approaches to protein engineering and modulation were 
evaluated. As one of the approaches to protein engineering, a strategy for the 
immobilization of proteins site-specifically via the N-terminus onto the microarray 
was developed. The chosen model proteins were cloned into a vector system that 
facilitates the expression of the protein with an N-terminal intein fusion. An extra 
cysteine residue was introduced at the junction of the intein and protein fusion. Upon 
expression of the intein-protein fusion, intein splices out, leaving the protein with an 
N-terminal cysteine. The proteins thus produced were applied onto thioester-
functionalized slides for uniform orientation. As a complementary method, intein 
based approach to site-specifically biotinylate proteins derived from yeast on their C-
terminus was successfully set up. Three different commercially available inteins were 
tested out. Amongst them one, the Sce VMA intein was chosen as the intein of choice 
because of its high yields and minimal in vivo cleavage. It was shown successfully 
that EGFP fused to Sce VMA intein and expressed from small scale cultures in yeast 
could be biotinylated at the C-terminus using the intein mediated thioester generation 
process. Further experiments were done to immobilize the biotinylated proteins onto 
avidin derived surfaces. Despite optimizing procedures the yields of biotinylated 
proteins was not sufficient to achieve immobilization on the microarray. While this 
problem could be solved by expressing the proteins in large scale cultures from yeast, 
it was not pursued further, as the protocol was not adaptable to high throughput 
immobilization. Hence it was concluded that obtaining biotinylated proteins in a high 
throughput manner from yeast, (e.g. in 96 well plates), was not feasible using this 
approach.  
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A selection scheme for evolving SrtA on phage has been setup. The selection scheme 
is a varied version of the product capture approach used to evolve enzymes on the 
phages. The selection scheme was at first proved by expressing SrtA with its C- 
terminus fused to its LPETG substrate (C-SrtA). When C-SrtA was incubated with 
G5-Biotin, it was able to catalyze the transfer of G5-Biotin onto its own C- terminus, 
thus proving the self-ligation ability of SrtA. C-SrtA was then successfully displayed 
on the phage and its activity was proven. Finally C-SrtA-T7 proved capable of 
ligating GG-TMR onto itself, thus demonstrating the success of the selection scheme. 
However the activity of SrtA on phage was such that we were unable to enrich it 
based on its activity from a pool of bare phages. Nevertheless, using this selection 
scheme and a library of random mutants of SrtA, enzymes with improved activity 
may be selected for in the future. A suitable screening method may then be used to 
identify the most active members. The screened pool can also be subjected to further 
rounds of mutagenesis and the selection might be repeated. The whole process can be 
continued until SrtA with desired activity evolves.  
 
A peptide library on phage was scanned for inhibitors to the SARS viral protease 
3CL. Using the affinity selection method that is routinely used to biopan peptide 
libraries on phage, a commercially available peptide library was scanned for affinity 
binders to the mutant 3CL protease immobilized on GST beads. After several rounds 
of affinity purification weak binders to the protease was identified. While we failed to 
identify strong binders from this library, using the protocols that were established 
during the course of this project, several commercially available peptide display 
libraries could be scanned against mutant proteases. This might yield good binders in 
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APPENDIX A  
Buffer A  
30 mM    Potassium Acetate 
100 mM   Rubidium Chloride 
10 mM    Calcium Chloride 
50 mM    Manganese Chloride 
15 % v/v   Glycerol 
pH to 5.8 with dilute Acetic acid, filter sterilize 
 
Buffer B  
10 mM    MOPS 
75 mM    Calcium Chloride 
10 mm    Rubidium Chloride 
15 % v/v   Glycerol 
pH to 6.5 with dilute NaOH, filer sterilize.  
 
Buffer H1  
50 mM    NaH2PO4·H2O  
300 mM    NaCl    
10 mM    Imidazole   







50 mM    NaH2PO4·H2O  
0.5 % v/v    Tween-20    
20 mM    Imidazole  
pH to 8.0 using NaOH. 
 
Buffer H3 
50 mM    NaH2PO4·H2O  
1.5 M     NaCl  
30 mM    Imidazole  
pH to 8.0 using NaOH. 
 
Buffer H4 
50 mM    NaH2PO4·H2O  
300 mM    NaCl    
250 mM    Imidazole   
pH to 8.0 using NaOH. 
 
Buffer H5 
50 mM    Tris base   
150 mM    NaCl    






20 mM    NaH2PO4·H2O  
100 mM    NaCl    
0.1 % v/v    Tween-20  
1 mM    EDTA    
1 mM    DTT  
pH 7.5   
 
Bufffer G2 
137 mM   NaCl 
3 mM    KCl 
8 mM    NaH2PO4
1.5 mM   KH2PO4
pH 7.4 with HCL. 
 
Buffer G3 
10 mM    Tris    
50 mM    GSH     
 
BUFFER G4 
10 mM    Tris     
1 mM    DTT    
1 mM    EDTA  




20 mM    Tris     
500 mM    NaCl    
0.1 %v/v   Tween -20 
pH 7.5  
 
Buffer C2 
20 mM    Tris     
1 M                 NaCl    




30 mM    MESNA 
1 mM     EDTA 
20 mM    Tris 




50 mM    Tris base    
150 mM    NaCl    
5 mM     CaCl2    
2 mM     2-ME    
Adjust pH to 7.5 using HCl. 
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Buffer R2  
10 % v/v   Glycerol  
50 mM    Tris (pH 6.8)   
2 mM    EDTA (pH 8)   
2 %    SDS    
100 mM   DTT    
Pinch     BPB    
 
Buffer C 
20 % v/v   PEG    
2.5 M    NaCl     
Autoclave and store at RT 
 
Buffer D 
50 %     PEG      
Autoclave and store at RT 
 
Buffer E  
10 mM    Tris (pH 6.8)    
1 mM    EDTA (pH 8)   
4 M    NaI  





Buffer F  
50 mM    NaH2PO4·H2O  
300 mM    NaCl    
Adjust pH to 8.0 using NaOH. 
 
Buffer G 
0.2 M    Glycine  
1 mg/mL   BSA 
pH 2.2 with HCl.  
 
Buffer H  
0.1 M     NaHCO3 (pH 8.6) 
5 mg/ml    BSA  
Filter sterilize, store at 4°C. 
 
2XYT broth (per liter)  
20 g    Tryptone  
10 g    Yeast Extract 
5 g    NaCl 








10X SD-URA (per liter) 
10 g     Yeast nitrogen base    
29.311 g    Ammonium Sulphate   
0.12 g     Adenine Sulphate   
0.12 g     L-Arginine (HCL)   
0.12 g     L-Histidine (HCL)   
0.18 g     L-Lysine(mono-HCL)  
0.12 g     L-Methionine   
0.3 g    L-phenylalanine   
0.12 g      L-trptophan   
0.18 g     L-tyrosine    
0.9 g     L-Valine    
0.36 g    L-Leucine    
0.18 g     L-Isoleucine   
The above components were dissolved in de-ionized water and filter sterilized  
Just before use, the 10X media is diluted to 1X in sterile de-ionized water and 2 % 









Cloning table: List of constructs, primers and primer features. 
NAME OF THE CLONEA SEQUENCE OF PRIMERS FEATURESC NAME OF THE 
PRIMERS 
pDONOR201-SrtA,B 
Staphylococcus aureus genomic 
DNA,  
(pDEST-17-SrtAB)
5’GGG GAC AAG TTT GAA AAA AGC AGG CTT  
TAC CAT GCA AGC TAA ACC TCA A 3’ 
5’GGG GAC CAC TTT GTA CAA GAA AGC TG GGT 












5’GGG GAC AAG TTT GTA CAA AAA AGC AGG 
CTC AAT GGT GAG CAA GGG CGA G 3’ 
5’AGG GAT AGG CTT ACC AAG GCC GGT TTC CGG 














 5’GGG GAC CAC TTT GTA CAA GAA AGC TGG GTT 
TCA CGT AG AAT CGA GAC CGA GGA GAG GGT 
TAG GGA TAG GCT TAC C 3’ 








5’ATT AGG CCC AGC CGG CC GGT GGC GGA TCT 
GAA GGC GGA GGA AGT GAG GGA GGT  GGA AGC 
GAA CAA GCT AAA CCT CAA ATT CCG 3’  
5’ GCC GTA ATT AGC GGC CGC TGC TTT GAC 
TTC TGT AGC TAC AAA GAT TTT ACG TTT TTC 
CCA AAC GCC TG 3’ 
Sfi I site, N 
terminus extension.  
 










5’ CAA TTA ACA TTA ATT ACT GCT GAT TAC AAT 
GAA AAG 3’ 
 
 

















5’ CTT TTC ATT GTA ATC ATC AGC AGT AAT TAA 
TGT TAA TTG 3’ 
 











5’ GGC GGT GGC GGT  GGC CAA GCT AAA CCT 
CAA ATT  CCG AAA 3’ (1)D
5’ GCATTATAT  GGA TCC CGGC GGT GGC GGT 
GGC CAA GCT AAA 3’ (2)D
5’ GCAA  CCCGGG  TTA  GTG ATG GTG ATG ACC 
GGT TTC CGG CAG 3’ (3)D 
5’ ACC GGT TTC CGG CAG  ACC ACC  TTT  GAC 
TTC   TGT  AGC TAC A 3’ (4)D
 


















 pDONOR-C-SrtA, Staphylococcus 
aureus genomic DNA. 
(pDEST17-C-SrtA) 
 
5’ GGG GAC AAG TTT G TA CAA AAA AGC AGG 
CTT TAC CAT G CA AGC TAA ACC TCA A  3’ (1)E
5’ ACC GGT TTC CGG CAG  ACC ACC  TTT  GAC 
TTC   TGT  AGC TAC A 3’ (2)E
5’GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC 



















5’GGG GAC AAG TTT GTA CAA AAA AGC AGG 
CTT CGA AGG AGA TAG AAC CAT GGT GAG  
CAA GGG CGA GGA G 3’ 
5’GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC 


















5’GGG GAC AAG TTT GTA CAA AAA AGC AGG 
CTT CGA AGG AGA TAG AAC CAT GGT GAG  
CAA GGG CGA GGA G 3’ 
5’GGG GAC CAC TTT GTA CAA GAA AGC TGG 

















5’ CAT TAA AGG TTC TTT CCT TAA TGG ATC AGC 
AGG TAG TGT TGG TTT TAA CAT TGA TTA TG 3’ 
5’ CAT AAT CAA TGT TAA AAC CAA CAC TAC CTG 
CTG ATC CAT TAA GGA AAG AAC CTT TAA TG 3’ 
 
Bases that were 
mutated 














10-3-B 5’ GGA GCT GTC GTA TTC CAG TC3’ 









A. Name of the clone includes vector name and the gene cloned into the vector and source of the gene is in italics and is underlined. The 
name of the subclones, derived from the parental clones is given in red. Subcloning was done either using RE based methods or using 
gateway methods. 
B. Constructs were made by colleagues in the lab, included in thesis because I made use of it. 
C. Features of the primers are highlighted as follows, Affinity tags in blue, Restriction enzyme sites in bold, linker sequences underlined. 
D. PCR was done at first using primers 1 and 4, the resultant PCR product was used for PCR using primers 2 and 3. 
E. PCR was done at first using primers 1 and 2, the resultant PCR product was used for PCR using 1 and 3. 
F. The Digestion of the pFAB5c.HIS-N-SrtA with EagI gets rid of the Gene III from the vector and converts it into a expression vector, 
pFAB5c.HIS-N-SrtA-EXP. The vector is now ready for expression of cloned fragment. Gene III is toxic to the bacterial cells if over 
expressed by IPTG induction and hence it is required to be removed before over expression from the lac promoter.  
G. All constructs given in this section were made using full plasmid PCR amplification using the same set of primers, to mutate the active 
site of SrtA. 
H. For details on PCR, SDM, TA cloning, gateway cloning and RE based cloning see Chapter 2 of thesis. 
I. Construct and primers gifted by Prof. Song Jian Xing. 
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Expression table: Expression conditions of different expression constructs. 




EXPRESSION CONDITIONS WESTERN BLOT CONDITIONS 
pDEST-17-SrtA BL-21-AI OD600 = 0.5, 0.2 % arabinose, 37 °C, 4 hrs Penta-HIS-HRP conjugate, 1/1000 dil in milk, 1hr, 
RT, 10 min each, 6 times, PBST (Tween 20, 0.1%) 
pDEST-17-EGFP-
V5 
BL-21-AI OD600 = 0.5, 0.2 % arabinose, RT, O/N Penta-HIS-HRP conjugate, 1/1000 dil in milk, 1hr, 






OD600 of 0.5, 1 mM, IPTG, 37°C , 4 hrs Penta-HIS-HRP conjugate, 1/1000 dil in milk, 1hr, 




BL-21-AI OD600 = 0.5, 0.2 % arabinose, 37°C, 4 hrs Penta-HIS-HRP conjugate, 1/1000 dil in milk, 1hr, 







Grown in SD-URA + glucose  media, OD600 = 
0.4, 2 % galactose, SD-URA, 30 °C, 24 hrs  
1°antibody: anti-CBD, 1/5000 dil in milk,  2° 
antibody: anti-Rabbit -HRP in milk, 1/ 5000 dil in 
milk, 1 hr RT , 10 min each, 6 times, PBST 





Grown in SD-URA + 2 % glucose  media, 
OD600 = 0.4, 2 % galactose , SD-URA , 30°C, 
24 hrs 
1° antibody: anti-CBD, 1/5000 dil in milk,  2° 
antibody: anti-Rabbit-HRP,1/ 5000 dilution in 
milk, 1 hr RT, 10 min each, 6 times, PBST 




BL21-DE3 OD600 of 0.5, 0.5 mM IPTG, RT, O/N Anti-GST HRP conjugated, 1/5000 dil in milk, 1 
hr, RT, 10 min each, 6 times, PBST (Tween 20, 
0.1%) 
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